JP2010538040A - アリールスルホニルアミノメチルホスホン酸誘導体、その製法及びその医薬組成物としての使用 - Google Patents

Info

Publication number

JP2010538040A

JP2010538040A JP2010523500A JP2010523500A JP2010538040A JP 2010538040 A JP2010538040 A JP 2010538040A JP 2010523500 A JP2010523500 A JP 2010523500A JP 2010523500 A JP2010523500 A JP 2010523500A JP 2010538040 A JP2010538040 A JP 2010538040A

Authority

JP

Japan

Prior art keywords

methyl

alkyl

amino

phenylsulfonyl

dichloro

Prior art date

2007-09-05

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Pending

Links

• Espacenet
• Global Dossier
• Discuss

• 238000002360 preparation method Methods 0.000 title claims description 19
• 239000002253 acid Substances 0.000 title abstract description 12
• 239000008194 pharmaceutical composition Substances 0.000 title description 13
• 239000000126 substance Substances 0.000 claims abstract description 16
• 239000003814 drug Substances 0.000 claims abstract description 9
• 229940079593 drug Drugs 0.000 claims abstract description 6
• -1 hydroxy, amino Chemical group 0.000 claims description 119
• 150000001875 compounds Chemical class 0.000 claims description 104
• 125000001072 heteroaryl group Chemical group 0.000 claims description 46
• 125000003118 aryl group Chemical group 0.000 claims description 43
• 229910052739 hydrogen Inorganic materials 0.000 claims description 42
• 150000003839 salts Chemical class 0.000 claims description 40
• 229910052799 carbon Inorganic materials 0.000 claims description 33
• 125000000592 heterocycloalkyl group Chemical group 0.000 claims description 33
• 238000006243 chemical reaction Methods 0.000 claims description 26
• 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims description 22
• ABLZXFCXXLZCGV-UHFFFAOYSA-N phosphonic acid group Chemical group P(O)(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 claims description 21
• 125000006272 (C3-C7) cycloalkyl group Chemical group 0.000 claims description 17
• 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 17
• XSCHRSMBECNVNS-UHFFFAOYSA-N quinoxaline Chemical compound N1=CC=NC2=CC=CC=C21 XSCHRSMBECNVNS-UHFFFAOYSA-N 0.000 claims description 17
• 125000004093 cyano group Chemical group *C#N 0.000 claims description 16
• 229910052736 halogen Inorganic materials 0.000 claims description 16
• 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 16
• 150000002367 halogens Chemical class 0.000 claims description 15
• 238000000034 method Methods 0.000 claims description 15
• WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 14
• SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 claims description 14
• GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 14
• 229910052794 bromium Inorganic materials 0.000 claims description 14
• 239000001257 hydrogen Substances 0.000 claims description 14
• 125000000217 alkyl group Chemical group 0.000 claims description 13
• 239000000460 chlorine Substances 0.000 claims description 13
• 229910052801 chlorine Inorganic materials 0.000 claims description 13
• 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 13
• 125000006239 protecting group Chemical group 0.000 claims description 13
• ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 12
• UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 claims description 12
• 229920001774 Perfluoroether Polymers 0.000 claims description 12
• 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 12
• 229910052757 nitrogen Inorganic materials 0.000 claims description 12
• 125000004432 carbon atom Chemical group C* 0.000 claims description 10
• AWJUIBRHMBBTKR-UHFFFAOYSA-N isoquinoline Chemical compound C1=NC=CC2=CC=CC=C21 AWJUIBRHMBBTKR-UHFFFAOYSA-N 0.000 claims description 10
• 125000001424 substituent group Chemical group 0.000 claims description 10
• PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims description 9
• SOXNOPBBWFDOMY-UHFFFAOYSA-N [(3,5-dichlorophenyl)sulfonyl-naphthalen-2-ylamino]methylphosphonic acid Chemical compound C=1C=C2C=CC=CC2=CC=1N(CP(O)(=O)O)S(=O)(=O)C1=CC(Cl)=CC(Cl)=C1 SOXNOPBBWFDOMY-UHFFFAOYSA-N 0.000 claims description 9
• 239000011737 fluorine Substances 0.000 claims description 9
• 229910052731 fluorine Inorganic materials 0.000 claims description 9
• 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 9
• 125000004104 aryloxy group Chemical group 0.000 claims description 8
• 125000005553 heteroaryloxy group Chemical group 0.000 claims description 8
• 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 8
• 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 8
• 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 7
• WCZVZNOTHYJIEI-UHFFFAOYSA-N cinnoline Chemical compound N1=NC=CC2=CC=CC=C21 WCZVZNOTHYJIEI-UHFFFAOYSA-N 0.000 claims description 7
• 239000003085 diluting agent Substances 0.000 claims description 7
• JWVCLYRUEFBMGU-UHFFFAOYSA-N quinazoline Chemical compound N1=CN=CC2=CC=CC=C21 JWVCLYRUEFBMGU-UHFFFAOYSA-N 0.000 claims description 7
• 208000001072 type 2 diabetes mellitus Diseases 0.000 claims description 7
• 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims description 6
• 125000003601 C2-C6 alkynyl group Chemical group 0.000 claims description 6
• OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 6
• 206010067584 Type 1 diabetes mellitus Diseases 0.000 claims description 6
• RQNCOYLVHUROPR-UHFFFAOYSA-N [(3,5-dichlorophenyl)sulfonyl-[5-(2-phenylethylcarbamoyl)naphthalen-1-yl]amino]methylphosphonic acid Chemical compound C=1C(Cl)=CC(Cl)=CC=1S(=O)(=O)N(CP(O)(=O)O)C(C1=CC=C2)=CC=CC1=C2C(=O)NCCC1=CC=CC=C1 RQNCOYLVHUROPR-UHFFFAOYSA-N 0.000 claims description 6
• 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 claims description 6
• 125000004541 benzoxazolyl group Chemical group O1C(=NC2=C1C=CC=C2)* 0.000 claims description 6
• 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims description 6
• 239000000969 carrier Substances 0.000 claims description 6
• 125000001715 oxadiazolyl group Chemical group 0.000 claims description 6
• 125000000714 pyrimidinyl group Chemical group 0.000 claims description 6
• UIYUGNHEKIRGKS-UHFFFAOYSA-N [(3,5-dichlorophenyl)sulfonyl-[5-(methylcarbamoyl)naphthalen-2-yl]amino]methylphosphonic acid Chemical compound C=1C=C2C(C(=O)NC)=CC=CC2=CC=1N(CP(O)(O)=O)S(=O)(=O)C1=CC(Cl)=CC(Cl)=C1 UIYUGNHEKIRGKS-UHFFFAOYSA-N 0.000 claims description 5
• PMTVKKJYDQFNAE-UHFFFAOYSA-N [(3,5-dichlorophenyl)sulfonyl-[6-[(2-phenylacetyl)amino]naphthalen-2-yl]amino]methylphosphonic acid Chemical compound C=1C(Cl)=CC(Cl)=CC=1S(=O)(=O)N(CP(O)(=O)O)C(C=C1C=C2)=CC=C1C=C2NC(=O)CC1=CC=CC=C1 PMTVKKJYDQFNAE-UHFFFAOYSA-N 0.000 claims description 5
• GWVODDYSBPISCN-UHFFFAOYSA-N [[5-(benzylcarbamoyl)naphthalen-1-yl]-(3,5-dichlorophenyl)sulfonylamino]methylphosphonic acid Chemical compound C=1C(Cl)=CC(Cl)=CC=1S(=O)(=O)N(CP(O)(=O)O)C(C1=CC=C2)=CC=CC1=C2C(=O)NCC1=CC=CC=C1 GWVODDYSBPISCN-UHFFFAOYSA-N 0.000 claims description 5
• MNWZTNAMMWIPMJ-UHFFFAOYSA-N [[5-(benzylcarbamoyl)naphthalen-2-yl]-(3,5-dichlorophenyl)sulfonylamino]methylphosphonic acid Chemical compound C=1C(Cl)=CC(Cl)=CC=1S(=O)(=O)N(CP(O)(=O)O)C(C=C1C=CC=2)=CC=C1C=2C(=O)NCC1=CC=CC=C1 MNWZTNAMMWIPMJ-UHFFFAOYSA-N 0.000 claims description 5
• HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 claims description 5
• 150000001721 carbon Chemical group 0.000 claims description 5
• 125000002534 ethynyl group Chemical group [H]C#C* 0.000 claims description 5
• 238000001727 in vivo Methods 0.000 claims description 5
• 125000004433 nitrogen atom Chemical group N* 0.000 claims description 5
• 125000006559 (C1-C3) alkylamino group Chemical group 0.000 claims description 4
• 125000002733 (C1-C6) fluoroalkyl group Chemical group 0.000 claims description 4
• CRRZQKAOKPWQLD-UHFFFAOYSA-N [(3,5-dichlorophenyl)sulfonyl-naphthalen-1-ylamino]methylphosphonic acid Chemical compound C=1C=CC2=CC=CC=C2C=1N(CP(O)(=O)O)S(=O)(=O)C1=CC(Cl)=CC(Cl)=C1 CRRZQKAOKPWQLD-UHFFFAOYSA-N 0.000 claims description 4
• YALORNPPFJVROW-UHFFFAOYSA-N [(3-bromo-5-chlorophenyl)sulfonyl-naphthalen-1-ylamino]methylphosphonic acid Chemical compound C=1C=CC2=CC=CC=C2C=1N(CP(O)(=O)O)S(=O)(=O)C1=CC(Cl)=CC(Br)=C1 YALORNPPFJVROW-UHFFFAOYSA-N 0.000 claims description 4
• PVRNWAMPSVSZKW-UHFFFAOYSA-N [(5-cyanonaphthalen-1-yl)-(3,5-dichlorophenyl)sulfonylamino]methylphosphonic acid Chemical compound C=1C=CC2=C(C#N)C=CC=C2C=1N(CP(O)(=O)O)S(=O)(=O)C1=CC(Cl)=CC(Cl)=C1 PVRNWAMPSVSZKW-UHFFFAOYSA-N 0.000 claims description 4
• GLHGDGAJHDGATA-UHFFFAOYSA-N [[5-[benzyl(methyl)carbamoyl]naphthalen-1-yl]-(3,5-dichlorophenyl)sulfonylamino]methylphosphonic acid Chemical compound C=1C=CC2=C(N(CP(O)(O)=O)S(=O)(=O)C=3C=C(Cl)C=C(Cl)C=3)C=CC=C2C=1C(=O)N(C)CC1=CC=CC=C1 GLHGDGAJHDGATA-UHFFFAOYSA-N 0.000 claims description 4
• 230000029936 alkylation Effects 0.000 claims description 4
• 238000005804 alkylation reaction Methods 0.000 claims description 4
• 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 4
• 125000005842 heteroatom Chemical group 0.000 claims description 4
• 150000007522 mineralic acids Chemical class 0.000 claims description 4
• 150000007524 organic acids Chemical class 0.000 claims description 4
• FLBAYUMRQUHISI-UHFFFAOYSA-N 1,8-naphthyridine Chemical compound N1=CC=CC2=CC=CN=C21 FLBAYUMRQUHISI-UHFFFAOYSA-N 0.000 claims description 3
• AXFWFPONLKABGG-UHFFFAOYSA-N [(2-bromonaphthalen-1-yl)-(3,5-dichlorophenyl)sulfonylamino]methylphosphonic acid Chemical compound BrC=1C=CC2=CC=CC=C2C=1N(CP(O)(=O)O)S(=O)(=O)C1=CC(Cl)=CC(Cl)=C1 AXFWFPONLKABGG-UHFFFAOYSA-N 0.000 claims description 3
• IXYUJRNHYPRJRY-UHFFFAOYSA-N [(2-chloronaphthalen-1-yl)-(3,5-dichlorophenyl)sulfonylamino]methylphosphonic acid Chemical compound ClC=1C=CC2=CC=CC=C2C=1N(CP(O)(=O)O)S(=O)(=O)C1=CC(Cl)=CC(Cl)=C1 IXYUJRNHYPRJRY-UHFFFAOYSA-N 0.000 claims description 3
• GAQOLQPTJSOIOR-UHFFFAOYSA-N [(2-cyanonaphthalen-1-yl)-(3,5-dichlorophenyl)sulfonylamino]methylphosphonic acid Chemical compound N#CC=1C=CC2=CC=CC=C2C=1N(CP(O)(=O)O)S(=O)(=O)C1=CC(Cl)=CC(Cl)=C1 GAQOLQPTJSOIOR-UHFFFAOYSA-N 0.000 claims description 3
• MGLDBGNFWUIZQO-UHFFFAOYSA-N [(3,5-dibromophenyl)sulfonyl-naphthalen-1-ylamino]methylphosphonic acid Chemical compound C=1C=CC2=CC=CC=C2C=1N(CP(O)(=O)O)S(=O)(=O)C1=CC(Br)=CC(Br)=C1 MGLDBGNFWUIZQO-UHFFFAOYSA-N 0.000 claims description 3
• GOAHMFYCMPWEIU-UHFFFAOYSA-N [(3,5-dichlorophenyl)sulfonyl-(2-methoxynaphthalen-1-yl)amino]methylphosphonic acid Chemical compound COC1=CC=C2C=CC=CC2=C1N(CP(O)(O)=O)S(=O)(=O)C1=CC(Cl)=CC(Cl)=C1 GOAHMFYCMPWEIU-UHFFFAOYSA-N 0.000 claims description 3
• ISVCSYCXBFWWOE-UHFFFAOYSA-N [(3,5-dichlorophenyl)sulfonyl-(2-methylquinolin-8-yl)amino]methylphosphonic acid Chemical compound C12=NC(C)=CC=C2C=CC=C1N(CP(O)(O)=O)S(=O)(=O)C1=CC(Cl)=CC(Cl)=C1 ISVCSYCXBFWWOE-UHFFFAOYSA-N 0.000 claims description 3
• YUSLHURSTZFFKS-UHFFFAOYSA-N [(3,5-dichlorophenyl)sulfonyl-(3-methylcinnolin-5-yl)amino]methylphosphonic acid Chemical compound C1=CC=C2N=NC(C)=CC2=C1N(CP(O)(O)=O)S(=O)(=O)C1=CC(Cl)=CC(Cl)=C1 YUSLHURSTZFFKS-UHFFFAOYSA-N 0.000 claims description 3
• HLYXLDPXCYQLSP-UHFFFAOYSA-N [(3,5-dichlorophenyl)sulfonyl-(3-methylnaphthalen-2-yl)amino]methylphosphonic acid Chemical compound CC1=CC2=CC=CC=C2C=C1N(CP(O)(O)=O)S(=O)(=O)C1=CC(Cl)=CC(Cl)=C1 HLYXLDPXCYQLSP-UHFFFAOYSA-N 0.000 claims description 3
• XLTIZIRXKLNZKA-UHFFFAOYSA-N [(3,5-dichlorophenyl)sulfonyl-(3-methylquinolin-5-yl)amino]methylphosphonic acid Chemical compound C12=CC(C)=CN=C2C=CC=C1N(CP(O)(O)=O)S(=O)(=O)C1=CC(Cl)=CC(Cl)=C1 XLTIZIRXKLNZKA-UHFFFAOYSA-N 0.000 claims description 3
• BGERLNNLQMVJTL-UHFFFAOYSA-N [(3,5-dichlorophenyl)sulfonyl-(4-methoxynaphthalen-1-yl)amino]methylphosphonic acid Chemical compound C12=CC=CC=C2C(OC)=CC=C1N(CP(O)(O)=O)S(=O)(=O)C1=CC(Cl)=CC(Cl)=C1 BGERLNNLQMVJTL-UHFFFAOYSA-N 0.000 claims description 3
• ZTEUXACEVOWDKK-UHFFFAOYSA-N [(3,5-dichlorophenyl)sulfonyl-(5-methoxynaphthalen-1-yl)amino]methylphosphonic acid Chemical compound C1=CC=C2C(OC)=CC=CC2=C1N(CP(O)(O)=O)S(=O)(=O)C1=CC(Cl)=CC(Cl)=C1 ZTEUXACEVOWDKK-UHFFFAOYSA-N 0.000 claims description 3
• NTXOBAKNKKVSIV-UHFFFAOYSA-N [(3,5-dichlorophenyl)sulfonyl-(6-pyrimidin-2-ylnaphthalen-2-yl)amino]methylphosphonic acid Chemical compound C=1C(Cl)=CC(Cl)=CC=1S(=O)(=O)N(CP(O)(=O)O)C(C=C1C=C2)=CC=C1C=C2C1=NC=CC=N1 NTXOBAKNKKVSIV-UHFFFAOYSA-N 0.000 claims description 3
• JEJAMFJGBMCRGT-UHFFFAOYSA-N [(3,5-dichlorophenyl)sulfonyl-(7-methylquinolin-8-yl)amino]methylphosphonic acid Chemical compound CC1=CC=C2C=CC=NC2=C1N(CP(O)(O)=O)S(=O)(=O)C1=CC(Cl)=CC(Cl)=C1 JEJAMFJGBMCRGT-UHFFFAOYSA-N 0.000 claims description 3
• FXELBOZOUJLMIW-UHFFFAOYSA-N [(3,5-dichlorophenyl)sulfonyl-[4-(dimethylamino)quinazolin-8-yl]amino]methylphosphonic acid Chemical compound C1=CC=C2C(N(C)C)=NC=NC2=C1N(CP(O)(O)=O)S(=O)(=O)C1=CC(Cl)=CC(Cl)=C1 FXELBOZOUJLMIW-UHFFFAOYSA-N 0.000 claims description 3
• FZVOXHYBRZUDSZ-UHFFFAOYSA-N [(3,5-dichlorophenyl)sulfonyl-[5-(dimethylsulfamoyl)naphthalen-1-yl]amino]methylphosphonic acid Chemical compound C1=CC=C2C(S(=O)(=O)N(C)C)=CC=CC2=C1N(CP(O)(O)=O)S(=O)(=O)C1=CC(Cl)=CC(Cl)=C1 FZVOXHYBRZUDSZ-UHFFFAOYSA-N 0.000 claims description 3
• QYPGMZKYQSZTPS-UHFFFAOYSA-N [(3,5-dichlorophenyl)sulfonyl-[5-(methylcarbamoyl)naphthalen-2-yl]amino]methyl-(2,2-dimethylpropanoyloxymethylperoxy)phosphinic acid Chemical compound C=1C=C2C(C(=O)NC)=CC=CC2=CC=1N(CP(O)(=O)OOCOC(=O)C(C)(C)C)S(=O)(=O)C1=CC(Cl)=CC(Cl)=C1 QYPGMZKYQSZTPS-UHFFFAOYSA-N 0.000 claims description 3
• QRQPRMRYMHTGHE-UHFFFAOYSA-N [(3,5-dichlorophenyl)sulfonyl-quinazolin-8-ylamino]methylphosphonic acid Chemical compound C=1C=CC2=CN=CN=C2C=1N(CP(O)(=O)O)S(=O)(=O)C1=CC(Cl)=CC(Cl)=C1 QRQPRMRYMHTGHE-UHFFFAOYSA-N 0.000 claims description 3
• DITDURCBHHLOAK-UHFFFAOYSA-N [(3,5-dichlorophenyl)sulfonyl-quinolin-3-ylamino]methylphosphonic acid Chemical compound C=1N=C2C=CC=CC2=CC=1N(CP(O)(=O)O)S(=O)(=O)C1=CC(Cl)=CC(Cl)=C1 DITDURCBHHLOAK-UHFFFAOYSA-N 0.000 claims description 3
• GGKYYPROBCRRGZ-UHFFFAOYSA-N [(3,5-dichlorophenyl)sulfonyl-quinolin-5-ylamino]methylphosphonic acid Chemical compound C=1C=CC2=NC=CC=C2C=1N(CP(O)(=O)O)S(=O)(=O)C1=CC(Cl)=CC(Cl)=C1 GGKYYPROBCRRGZ-UHFFFAOYSA-N 0.000 claims description 3
• CZEKNPZDXASHMG-UHFFFAOYSA-N [(3,5-dichlorophenyl)sulfonyl-quinolin-6-ylamino]methylphosphonic acid Chemical compound C=1C=C2N=CC=CC2=CC=1N(CP(O)(=O)O)S(=O)(=O)C1=CC(Cl)=CC(Cl)=C1 CZEKNPZDXASHMG-UHFFFAOYSA-N 0.000 claims description 3
• SZOAXTFCOABKDQ-UHFFFAOYSA-N [(3,5-dichlorophenyl)sulfonyl-quinolin-7-ylamino]methylphosphonic acid Chemical compound C=1C=C2C=CC=NC2=CC=1N(CP(O)(=O)O)S(=O)(=O)C1=CC(Cl)=CC(Cl)=C1 SZOAXTFCOABKDQ-UHFFFAOYSA-N 0.000 claims description 3
• UPEWGINAZOKEGZ-UHFFFAOYSA-N [(3,5-dichlorophenyl)sulfonyl-quinolin-8-ylamino]methylphosphonic acid Chemical compound C=1C=CC2=CC=CN=C2C=1N(CP(O)(=O)O)S(=O)(=O)C1=CC(Cl)=CC(Cl)=C1 UPEWGINAZOKEGZ-UHFFFAOYSA-N 0.000 claims description 3
• CLAVFXVMJIHCSP-UHFFFAOYSA-N [(3,5-dichlorophenyl)sulfonyl-quinoxalin-5-ylamino]methylphosphonic acid Chemical compound C=1C=CC2=NC=CN=C2C=1N(CP(O)(=O)O)S(=O)(=O)C1=CC(Cl)=CC(Cl)=C1 CLAVFXVMJIHCSP-UHFFFAOYSA-N 0.000 claims description 3
• QKCLTQMWGIRKPU-UHFFFAOYSA-N [(3,5-dichlorophenyl)sulfonyl-quinoxalin-6-ylamino]methylphosphonic acid Chemical compound C=1C=C2N=CC=NC2=CC=1N(CP(O)(=O)O)S(=O)(=O)C1=CC(Cl)=CC(Cl)=C1 QKCLTQMWGIRKPU-UHFFFAOYSA-N 0.000 claims description 3
• VKUAXWFNKKUZCQ-UHFFFAOYSA-N [(3-bromo-5-methylphenyl)sulfonyl-naphthalen-1-ylamino]methylphosphonic acid Chemical compound CC1=CC(Br)=CC(S(=O)(=O)N(CP(O)(O)=O)C=2C3=CC=CC=C3C=CC=2)=C1 VKUAXWFNKKUZCQ-UHFFFAOYSA-N 0.000 claims description 3
• CAWZAHALFAPXFF-UHFFFAOYSA-N [(3-chloro-5-methylphenyl)sulfonyl-naphthalen-1-ylamino]methylphosphonic acid Chemical compound CC1=CC(Cl)=CC(S(=O)(=O)N(CP(O)(O)=O)C=2C3=CC=CC=C3C=CC=2)=C1 CAWZAHALFAPXFF-UHFFFAOYSA-N 0.000 claims description 3
• XABYCTJRTCHRAO-UHFFFAOYSA-N [[(3,5-dichlorophenyl)sulfonyl-[5-(methylcarbamoyl)naphthalen-2-yl]amino]methyl-(propan-2-yloxycarbonyloxymethoxy)phosphoryl]oxymethyl propan-2-yl carbonate Chemical compound C=1C=C2C(C(=O)NC)=CC=CC2=CC=1N(CP(=O)(OCOC(=O)OC(C)C)OCOC(=O)OC(C)C)S(=O)(=O)C1=CC(Cl)=CC(Cl)=C1 XABYCTJRTCHRAO-UHFFFAOYSA-N 0.000 claims description 3
• MLEWRZVFDLSKDS-UHFFFAOYSA-N [[(3,5-dichlorophenyl)sulfonyl-quinolin-6-ylamino]methyl-(2,2-dimethylpropanoyloxymethylperoxy)phosphoryl]peroxymethyl 2,2-dimethylpropanoate Chemical compound C=1C=C2N=CC=CC2=CC=1N(CP(=O)(OOCOC(=O)C(C)(C)C)OOCOC(=O)C(C)(C)C)S(=O)(=O)C1=CC(Cl)=CC(Cl)=C1 MLEWRZVFDLSKDS-UHFFFAOYSA-N 0.000 claims description 3
• PZQCNOWFKVNALR-UHFFFAOYSA-N [[(3,5-dichlorophenyl)sulfonyl-quinolin-6-ylamino]methyl-(propan-2-yloxycarbonyloxymethoxy)phosphoryl]oxymethyl propan-2-yl carbonate Chemical compound C=1C=C2N=CC=CC2=CC=1N(CP(=O)(OCOC(=O)OC(C)C)OCOC(=O)OC(C)C)S(=O)(=O)C1=CC(Cl)=CC(Cl)=C1 PZQCNOWFKVNALR-UHFFFAOYSA-N 0.000 claims description 3
• FHNYKHOSPOFFPR-UHFFFAOYSA-N [[(3-bromo-5-chlorophenyl)sulfonyl-naphthalen-1-ylamino]methyl-(2,2-dimethylpropanoyloxymethylperoxy)phosphoryl]peroxymethyl 2,2-dimethylpropanoate Chemical compound C=1C=CC2=CC=CC=C2C=1N(CP(=O)(OOCOC(=O)C(C)(C)C)OOCOC(=O)C(C)(C)C)S(=O)(=O)C1=CC(Cl)=CC(Br)=C1 FHNYKHOSPOFFPR-UHFFFAOYSA-N 0.000 claims description 3
• NDXKHTHJTZPNDO-UHFFFAOYSA-N [[(3-bromo-5-chlorophenyl)sulfonyl-naphthalen-1-ylamino]methyl-(propan-2-yloxycarbonyloxymethoxy)phosphoryl]oxymethyl propan-2-yl carbonate Chemical compound C=1C=CC2=CC=CC=C2C=1N(CP(=O)(OCOC(=O)OC(C)C)OCOC(=O)OC(C)C)S(=O)(=O)C1=CC(Cl)=CC(Br)=C1 NDXKHTHJTZPNDO-UHFFFAOYSA-N 0.000 claims description 3
• PFFCIMWBNNAUGS-UHFFFAOYSA-N [[2-(benzylcarbamoyl)naphthalen-1-yl]-(3,5-dichlorophenyl)sulfonylamino]methylphosphonic acid Chemical compound C=1C(Cl)=CC(Cl)=CC=1S(=O)(=O)N(CP(O)(=O)O)C(C1=CC=CC=C1C=C1)=C1C(=O)NCC1=CC=CC=C1 PFFCIMWBNNAUGS-UHFFFAOYSA-N 0.000 claims description 3
• 125000002619 bicyclic group Chemical group 0.000 claims description 3
• YACKEPLHDIMKIO-UHFFFAOYSA-N methylphosphonic acid Chemical class CP(O)(O)=O YACKEPLHDIMKIO-UHFFFAOYSA-N 0.000 claims description 3
• LFSXCDWNBUNEEM-UHFFFAOYSA-N phthalazine Chemical compound C1=NN=CC2=CC=CC=C21 LFSXCDWNBUNEEM-UHFFFAOYSA-N 0.000 claims description 3
• BWESROVQGZSBRX-UHFFFAOYSA-N pyrido[3,2-d]pyrimidine Chemical compound C1=NC=NC2=CC=CN=C21 BWESROVQGZSBRX-UHFFFAOYSA-N 0.000 claims description 3
• JOZPEVMCAKXSEY-UHFFFAOYSA-N pyrimido[5,4-d]pyrimidine Chemical compound N1=CN=CC2=NC=NC=C21 JOZPEVMCAKXSEY-UHFFFAOYSA-N 0.000 claims description 3
• 125000006273 (C1-C3) alkyl group Chemical group 0.000 claims description 2
• VMLKTERJLVWEJJ-UHFFFAOYSA-N 1,5-naphthyridine Chemical compound C1=CC=NC2=CC=CN=C21 VMLKTERJLVWEJJ-UHFFFAOYSA-N 0.000 claims description 2
• GCJZOULMNAVQQQ-UHFFFAOYSA-N ClC=1C=C(C=C(C1)Cl)S(=O)(=O)N(C1=C(C=CC2=CC=CC=C12)CC)CP(O)(O)=O Chemical compound ClC=1C=C(C=C(C1)Cl)S(=O)(=O)N(C1=C(C=CC2=CC=CC=C12)CC)CP(O)(O)=O GCJZOULMNAVQQQ-UHFFFAOYSA-N 0.000 claims description 2
• 125000003277 amino group Chemical group 0.000 claims description 2
• 125000005100 aryl amino carbonyl group Chemical group 0.000 claims description 2
• 125000005418 aryl aryl group Chemical group 0.000 claims description 2
• 125000005129 aryl carbonyl group Chemical group 0.000 claims description 2
• 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 claims description 2
• 125000000753 cycloalkyl group Chemical group 0.000 claims description 2
• 125000006263 dimethyl aminosulfonyl group Chemical group [H]C([H])([H])N(C([H])([H])[H])S(*)(=O)=O 0.000 claims description 2
• 125000005010 perfluoroalkyl group Chemical group 0.000 claims description 2
• 125000001042 pteridinyl group Chemical group N1=C(N=CC2=NC=CN=C12)* 0.000 claims description 2
• 238000004519 manufacturing process Methods 0.000 claims 1
• 208000030159 metabolic disease Diseases 0.000 abstract description 7
• 206010012601 diabetes mellitus Diseases 0.000 abstract description 4
• XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 414
• 238000001819 mass spectrum Methods 0.000 description 190
• WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 165
• VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 158
• 239000000741 silica gel Substances 0.000 description 154
• 229910002027 silica gel Inorganic materials 0.000 description 154
• RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 153
• YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 150
• OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 135
• DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 106
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 94
• 239000003208 petroleum Substances 0.000 description 71
• 239000012071 phase Substances 0.000 description 50
• PQLVXDKIJBQVDF-UHFFFAOYSA-N acetic acid;hydrate Chemical compound O.CC(O)=O PQLVXDKIJBQVDF-UHFFFAOYSA-N 0.000 description 49
• 230000002441 reversible effect Effects 0.000 description 49
• WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 48
• 239000013543 active substance Substances 0.000 description 39
• ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 36
• 239000000243 solution Substances 0.000 description 34
• VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 33
• 239000000203 mixture Substances 0.000 description 33
• 239000011541 reaction mixture Substances 0.000 description 33
• CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 32
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 30
• XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 29
• HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 27
• YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 24
• ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 21
• QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 18
• 108010046163 Glycogen Phosphorylase Proteins 0.000 description 16
• 102000007390 Glycogen Phosphorylase Human genes 0.000 description 16
• 125000004177 diethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 16
• HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 16
• 229910052943 magnesium sulfate Inorganic materials 0.000 description 16
• 235000019341 magnesium sulphate Nutrition 0.000 description 16
• 239000002904 solvent Substances 0.000 description 16
• KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 15
• 239000003826 tablet Substances 0.000 description 15
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 13
• 239000003112 inhibitor Substances 0.000 description 13
• 229920002527 Glycogen Polymers 0.000 description 12
• JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 12
• 229940096919 glycogen Drugs 0.000 description 12
• 230000003993 interaction Effects 0.000 description 12
• 108010059000 Protein Phosphatase 1 Proteins 0.000 description 11
• 102000005569 Protein Phosphatase 1 Human genes 0.000 description 11
• 239000003480 eluent Substances 0.000 description 11
• 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 11
• 238000001816 cooling Methods 0.000 description 10
• RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 9
• CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 9
• KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 9
• KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 9
• YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 9
• 230000002265 prevention Effects 0.000 description 9
• 229920002261 Corn starch Polymers 0.000 description 8
• PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
• JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 8
• 239000002585 base Substances 0.000 description 8
• 239000008120 corn starch Substances 0.000 description 8
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
• 235000019359 magnesium stearate Nutrition 0.000 description 8
• 238000003786 synthesis reaction Methods 0.000 description 8
• 229960000583 acetic acid Drugs 0.000 description 7
• 230000015572 biosynthetic process Effects 0.000 description 7
• 201000010099 disease Diseases 0.000 description 7
• 239000012074 organic phase Substances 0.000 description 7
• 239000001267 polyvinylpyrrolidone Substances 0.000 description 7
• 229920000036 polyvinylpyrrolidone Polymers 0.000 description 7
• 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 7
• 229940002612 prodrug Drugs 0.000 description 7
• 239000000651 prodrug Substances 0.000 description 7
• HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 6
• IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
• 208000002249 Diabetes Complications Diseases 0.000 description 6
• UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 6
• GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 6
• CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 6
• QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 6
• 239000003054 catalyst Substances 0.000 description 6
• 239000000284 extract Substances 0.000 description 6
• 239000004615 ingredient Substances 0.000 description 6
• 239000008101 lactose Substances 0.000 description 6
• BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 6
• 239000002244 precipitate Substances 0.000 description 6
• UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 6
• CSRZQMIRAZTJOY-UHFFFAOYSA-N trimethylsilyl iodide Chemical compound C[Si](C)(C)I CSRZQMIRAZTJOY-UHFFFAOYSA-N 0.000 description 6
• 206010012655 Diabetic complications Diseases 0.000 description 5
• 239000000556 agonist Substances 0.000 description 5
• 150000001340 alkali metals Chemical class 0.000 description 5
• 239000005557 antagonist Substances 0.000 description 5
• 239000012300 argon atmosphere Substances 0.000 description 5
• 239000002775 capsule Substances 0.000 description 5
• 238000004587 chromatography analysis Methods 0.000 description 5
• 235000015165 citric acid Nutrition 0.000 description 5
• 239000012043 crude product Substances 0.000 description 5
• MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 5
• 230000002401 inhibitory effect Effects 0.000 description 5
• 239000013067 intermediate product Substances 0.000 description 5
• 239000000725 suspension Substances 0.000 description 5
• UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 4
• HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
• FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 4
• ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 4
• IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
• VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 4
• KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
• MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 4
• NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
• FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 4
• 239000003708 ampul Substances 0.000 description 4
• RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 4
• WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 4
• 238000003776 cleavage reaction Methods 0.000 description 4
• OPQARKPSCNTWTJ-UHFFFAOYSA-L copper(ii) acetate Chemical compound [Cu+2].CC([O-])=O.CC([O-])=O OPQARKPSCNTWTJ-UHFFFAOYSA-L 0.000 description 4
• 230000000694 effects Effects 0.000 description 4
• 239000000706 filtrate Substances 0.000 description 4
• 125000000623 heterocyclic group Chemical group 0.000 description 4
• 150000002431 hydrogen Chemical class 0.000 description 4
• 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 4
• 230000008569 process Effects 0.000 description 4
• 150000003254 radicals Chemical class 0.000 description 4
• 230000007017 scission Effects 0.000 description 4
• 238000003756 stirring Methods 0.000 description 4
• 239000000829 suppository Substances 0.000 description 4
• 239000011975 tartaric acid Substances 0.000 description 4
• 235000002906 tartaric acid Nutrition 0.000 description 4
• 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 4
• 238000012360 testing method Methods 0.000 description 4
• FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 4
• VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 4
• 238000010626 work up procedure Methods 0.000 description 4
• RAXXELZNTBOGNW-UHFFFAOYSA-N 1H-imidazole Chemical compound C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
• RJSQINMKOSOUGT-UHFFFAOYSA-N 3,5-dichlorobenzenesulfonyl chloride Chemical compound ClC1=CC(Cl)=CC(S(Cl)(=O)=O)=C1 RJSQINMKOSOUGT-UHFFFAOYSA-N 0.000 description 3
• ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 3
• WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
• FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 3
• LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
• WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
• WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 3
• HSHXDCVZWHOWCS-UHFFFAOYSA-N N'-hexadecylthiophene-2-carbohydrazide Chemical compound CCCCCCCCCCCCCCCCNNC(=O)c1cccs1 HSHXDCVZWHOWCS-UHFFFAOYSA-N 0.000 description 3
• DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
• RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 3
• NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 3
• 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 3
• 229910052783 alkali metal Inorganic materials 0.000 description 3
• 150000001408 amides Chemical class 0.000 description 3
• 239000002333 angiotensin II receptor antagonist Substances 0.000 description 3
• 239000008346 aqueous phase Substances 0.000 description 3
• QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
• 125000004369 butenyl group Chemical group C(=CCC)* 0.000 description 3
• 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
• 125000000480 butynyl group Chemical group [*]C#CC([H])([H])C([H])([H])[H] 0.000 description 3
• 239000003638 chemical reducing agent Substances 0.000 description 3
• JHYNXXBAHWPABC-UHFFFAOYSA-N chloromethyl propan-2-yl carbonate Chemical compound CC(C)OC(=O)OCCl JHYNXXBAHWPABC-UHFFFAOYSA-N 0.000 description 3
• 125000001028 difluoromethyl group Chemical group [H]C(F)(F)* 0.000 description 3
• 239000002934 diuretic Substances 0.000 description 3
• 229940030606 diuretics Drugs 0.000 description 3
• 150000002148 esters Chemical class 0.000 description 3
• 239000007903 gelatin capsule Substances 0.000 description 3
• 239000012362 glacial acetic acid Substances 0.000 description 3
• 239000008103 glucose Substances 0.000 description 3
• 235000011187 glycerol Nutrition 0.000 description 3
• 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 3
• 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 3
• 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 3
• NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 3
• 239000011630 iodine Substances 0.000 description 3
• 229910052740 iodine Inorganic materials 0.000 description 3
• 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 3
• 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 3
• 210000004185 liver Anatomy 0.000 description 3
• 125000002950 monocyclic group Chemical group 0.000 description 3
• ROSSPLLTJZRGOP-UHFFFAOYSA-N n-(6-aminonaphthalen-2-yl)-3,5-dichloro-n-(diethoxyphosphorylmethyl)benzenesulfonamide Chemical compound C=1C=C2C=C(N)C=CC2=CC=1N(CP(=O)(OCC)OCC)S(=O)(=O)C1=CC(Cl)=CC(Cl)=C1 ROSSPLLTJZRGOP-UHFFFAOYSA-N 0.000 description 3
• VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
• 229910052760 oxygen Inorganic materials 0.000 description 3
• 239000001301 oxygen Substances 0.000 description 3
• 229910052763 palladium Inorganic materials 0.000 description 3
• UEZVMMHDMIWARA-UHFFFAOYSA-M phosphonate Chemical compound [O-]P(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-M 0.000 description 3
• 229910000027 potassium carbonate Inorganic materials 0.000 description 3
• NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
• 125000004368 propenyl group Chemical group C(=CC)* 0.000 description 3
• 125000002568 propynyl group Chemical group [*]C#CC([H])([H])[H] 0.000 description 3
• 229910000029 sodium carbonate Inorganic materials 0.000 description 3
• 239000000600 sorbitol Substances 0.000 description 3
• 229910052717 sulfur Inorganic materials 0.000 description 3
• 239000011593 sulfur Substances 0.000 description 3
• ITMCEJHCFYSIIV-UHFFFAOYSA-N triflic acid Chemical compound OS(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-N 0.000 description 3
• NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 2
• HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 description 2
• BBVIDBNAYOIXOE-UHFFFAOYSA-N 1,2,4-oxadiazole Chemical compound C=1N=CON=1 BBVIDBNAYOIXOE-UHFFFAOYSA-N 0.000 description 2
• WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 2
• ZXSQEZNORDWBGZ-UHFFFAOYSA-N 1,3-dihydropyrrolo[2,3-b]pyridin-2-one Chemical compound C1=CN=C2NC(=O)CC2=C1 ZXSQEZNORDWBGZ-UHFFFAOYSA-N 0.000 description 2
• KBPLFHHGFOOTCA-UHFFFAOYSA-N 1-Octanol Chemical compound CCCCCCCCO KBPLFHHGFOOTCA-UHFFFAOYSA-N 0.000 description 2
• FCEHBMOGCRZNNI-UHFFFAOYSA-N 1-benzothiophene Chemical compound C1=CC=C2SC=CC2=C1 FCEHBMOGCRZNNI-UHFFFAOYSA-N 0.000 description 2
• BWZVCCNYKMEVEX-UHFFFAOYSA-N 2,4,6-Trimethylpyridine Chemical compound CC1=CC(C)=NC(C)=C1 BWZVCCNYKMEVEX-UHFFFAOYSA-N 0.000 description 2
• HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
• ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 2
• KFGXRXRORAAYQR-UHFFFAOYSA-N 2-[difluoro-[fluoro(trifluoromethoxy)amino]oxymethoxy]-2-hydroxyacetonitrile Chemical compound C(#N)C(OC(ON(F)OC(F)(F)F)(F)F)O KFGXRXRORAAYQR-UHFFFAOYSA-N 0.000 description 2
• JZMQHUUFWYXLKZ-UHFFFAOYSA-N 3,5-dichloro-n-naphthalen-1-ylbenzenesulfonamide Chemical compound ClC1=CC(Cl)=CC(S(=O)(=O)NC=2C3=CC=CC=C3C=CC=2)=C1 JZMQHUUFWYXLKZ-UHFFFAOYSA-N 0.000 description 2
• ANIPLEXJCOPVAB-UHFFFAOYSA-N 3,5-dichloro-n-quinolin-6-ylbenzenesulfonamide Chemical compound ClC1=CC(Cl)=CC(S(=O)(=O)NC=2C=C3C=CC=NC3=CC=2)=C1 ANIPLEXJCOPVAB-UHFFFAOYSA-N 0.000 description 2
• NNAMJCQDGOBXCO-UHFFFAOYSA-N 3-(5-bromonaphthalen-2-yl)-5-methyl-1,2,4-oxadiazole Chemical compound O1C(C)=NC(C=2C=C3C=CC=C(Br)C3=CC=2)=N1 NNAMJCQDGOBXCO-UHFFFAOYSA-N 0.000 description 2
• NCGKGUZFWBKTAX-UHFFFAOYSA-N 3-(6-bromonaphthalen-2-yl)-5-methyl-1,2,4-oxadiazole Chemical compound O1C(C)=NC(C=2C=C3C=CC(Br)=CC3=CC=2)=N1 NCGKGUZFWBKTAX-UHFFFAOYSA-N 0.000 description 2
• GKORYRVRMKXZLU-UHFFFAOYSA-N 3-chloro-n-(diethoxyphosphorylmethyl)-n-naphthalen-1-yl-5-nitrobenzenesulfonamide Chemical compound C=1C=CC2=CC=CC=C2C=1N(CP(=O)(OCC)OCC)S(=O)(=O)C1=CC(Cl)=CC([N+]([O-])=O)=C1 GKORYRVRMKXZLU-UHFFFAOYSA-N 0.000 description 2
• VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 2
• SQYLZNMEMRKNFK-UHFFFAOYSA-N 4-n,4-n-dimethylquinazoline-4,8-diamine Chemical compound C1=CC=C2C(N(C)C)=NC=NC2=C1N SQYLZNMEMRKNFK-UHFFFAOYSA-N 0.000 description 2
• NKLRUHXKMNMOSS-UHFFFAOYSA-N 5-[(3,5-dichlorophenyl)sulfonylamino]naphthalene-1-carboxamide Chemical compound C1=CC=C2C(C(=O)N)=CC=CC2=C1NS(=O)(=O)C1=CC(Cl)=CC(Cl)=C1 NKLRUHXKMNMOSS-UHFFFAOYSA-N 0.000 description 2
• JZYIUCIAAPWMLY-UHFFFAOYSA-N 5-[(3,5-dichlorophenyl)sulfonylamino]naphthalene-1-carboxylic acid Chemical compound C1=CC=C2C(C(=O)O)=CC=CC2=C1NS(=O)(=O)C1=CC(Cl)=CC(Cl)=C1 JZYIUCIAAPWMLY-UHFFFAOYSA-N 0.000 description 2
• KBQBIOPJKCPWOB-UHFFFAOYSA-N 6-[(3,5-dichlorophenyl)sulfonylamino]naphthalene-1-carboxylic acid Chemical compound C=1C=C2C(C(=O)O)=CC=CC2=CC=1NS(=O)(=O)C1=CC(Cl)=CC(Cl)=C1 KBQBIOPJKCPWOB-UHFFFAOYSA-N 0.000 description 2
• RJFHWGYLSUAYKE-UHFFFAOYSA-N 6-[(3,5-dimethylphenyl)sulfonylamino]-n-methylnaphthalene-1-carboxamide Chemical compound C=1C=C2C(C(=O)NC)=CC=CC2=CC=1NS(=O)(=O)C1=CC(C)=CC(C)=C1 RJFHWGYLSUAYKE-UHFFFAOYSA-N 0.000 description 2
• XJDOOLQDMRVKLV-UHFFFAOYSA-N 6-[diethoxyphosphorylmethyl-(3,5-dimethylphenyl)sulfonylamino]-n-methylnaphthalene-1-carboxamide Chemical compound C=1C=C2C(C(=O)NC)=CC=CC2=CC=1N(CP(=O)(OCC)OCC)S(=O)(=O)C1=CC(C)=CC(C)=C1 XJDOOLQDMRVKLV-UHFFFAOYSA-N 0.000 description 2
• FVTCTGBTQHAYJI-UHFFFAOYSA-N 6-bromo-n'-hydroxynaphthalene-2-carboximidamide Chemical compound C1=C(Br)C=CC2=CC(C(=N)NO)=CC=C21 FVTCTGBTQHAYJI-UHFFFAOYSA-N 0.000 description 2
• KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
• VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
• 201000001320 Atherosclerosis Diseases 0.000 description 2
• 210000002237 B-cell of pancreatic islet Anatomy 0.000 description 2
• 206010007558 Cardiac failure chronic Diseases 0.000 description 2
• NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 2
• ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 2
• IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 2
• DTHNMHAUYICORS-KTKZVXAJSA-N Glucagon-like peptide 1 Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1N=CNC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 DTHNMHAUYICORS-KTKZVXAJSA-N 0.000 description 2
• DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Natural products NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
• 239000004471 Glycine Substances 0.000 description 2
• 101001067946 Homo sapiens Protein phosphatase 1 regulatory subunit 3A Proteins 0.000 description 2
• WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical compound Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 description 2
• 206010020772 Hypertension Diseases 0.000 description 2
• SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
• AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
• BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 2
• LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
• SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 2
• PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
• CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical group CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 2
• 208000008589 Obesity Diseases 0.000 description 2
• URLKBWYHVLBVBO-UHFFFAOYSA-N Para-Xylene Chemical group CC1=CC=C(C)C=C1 URLKBWYHVLBVBO-UHFFFAOYSA-N 0.000 description 2
• 102100038831 Peroxisome proliferator-activated receptor alpha Human genes 0.000 description 2
• 239000002202 Polyethylene glycol Substances 0.000 description 2
• OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 2
• 102100034503 Protein phosphatase 1 regulatory subunit 3A Human genes 0.000 description 2
• KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 2
• YASAKCUCGLMORW-UHFFFAOYSA-N Rosiglitazone Chemical compound C=1C=CC=NC=1N(C)CCOC(C=C1)=CC=C1CC1SC(=O)NC1=O YASAKCUCGLMORW-UHFFFAOYSA-N 0.000 description 2
• UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
• RAHZWNYVWXNFOC-UHFFFAOYSA-N Sulphur dioxide Chemical compound O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 description 2
• GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
• DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 2
• 230000002378 acidificating effect Effects 0.000 description 2
• 150000007513 acids Chemical class 0.000 description 2
• 235000004279 alanine Nutrition 0.000 description 2
• 229910000272 alkali metal oxide Inorganic materials 0.000 description 2
• 229910001860 alkaline earth metal hydroxide Inorganic materials 0.000 description 2
• 125000003282 alkyl amino group Chemical group 0.000 description 2
• 239000002168 alkylating agent Substances 0.000 description 2
• 229940100198 alkylating agent Drugs 0.000 description 2
• 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
• 235000001014 amino acid Nutrition 0.000 description 2
• QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
• 239000007864 aqueous solution Substances 0.000 description 2
• IOJUPLGTWVMSFF-UHFFFAOYSA-N benzothiazole Chemical compound C1=CC=C2SC=NC2=C1 IOJUPLGTWVMSFF-UHFFFAOYSA-N 0.000 description 2
• 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 2
• WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
• 239000003613 bile acid Substances 0.000 description 2
• 239000004327 boric acid Substances 0.000 description 2
• IYYIVELXUANFED-UHFFFAOYSA-N bromo(trimethyl)silane Chemical compound C[Si](C)(C)Br IYYIVELXUANFED-UHFFFAOYSA-N 0.000 description 2
• 239000001506 calcium phosphate Substances 0.000 description 2
• 229910000389 calcium phosphate Inorganic materials 0.000 description 2
• 235000011010 calcium phosphates Nutrition 0.000 description 2
• PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 2
• 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
• 210000004027 cell Anatomy 0.000 description 2
• 239000003153 chemical reaction reagent Substances 0.000 description 2
• 229960001701 chloroform Drugs 0.000 description 2
• JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 2
• PAFZNILMFXTMIY-UHFFFAOYSA-N cyclohexylamine Chemical compound NC1CCCCC1 PAFZNILMFXTMIY-UHFFFAOYSA-N 0.000 description 2
• NNBZCPXTIHJBJL-UHFFFAOYSA-N decalin Chemical compound C1CCCC2CCCCC21 NNBZCPXTIHJBJL-UHFFFAOYSA-N 0.000 description 2
• 230000006806 disease prevention Effects 0.000 description 2
• 239000012153 distilled water Substances 0.000 description 2
• 239000012154 double-distilled water Substances 0.000 description 2
• 238000005516 engineering process Methods 0.000 description 2
• 238000009472 formulation Methods 0.000 description 2
• 239000001530 fumaric acid Substances 0.000 description 2
• 150000002334 glycols Chemical class 0.000 description 2
• 239000008187 granular material Substances 0.000 description 2
• 125000006038 hexenyl group Chemical group 0.000 description 2
• 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
• 150000004678 hydrides Chemical class 0.000 description 2
• 239000005457 ice water Substances 0.000 description 2
• PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical group II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 2
• JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
• UBJFKNSINUCEAL-UHFFFAOYSA-N lithium;2-methylpropane Chemical compound [Li+].C[C-](C)C UBJFKNSINUCEAL-UHFFFAOYSA-N 0.000 description 2
• IVSZLXZYQVIEFR-UHFFFAOYSA-N m-xylene Chemical group CC1=CC=CC(C)=C1 IVSZLXZYQVIEFR-UHFFFAOYSA-N 0.000 description 2
• VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 2
• 239000011976 maleic acid Substances 0.000 description 2
• 239000000463 material Substances 0.000 description 2
• UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 2
• 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 2
• 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 2
• UAEPNZWRGJTJPN-UHFFFAOYSA-N methylcyclohexane Chemical compound CC1CCCCC1 UAEPNZWRGJTJPN-UHFFFAOYSA-N 0.000 description 2
• LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
• 125000002757 morpholinyl group Chemical group 0.000 description 2
• FQNSIFPEUHCYOS-UHFFFAOYSA-N n,n-dimethyl-8-nitroquinazolin-4-amine Chemical compound C1=CC=C2C(N(C)C)=NC=NC2=C1[N+]([O-])=O FQNSIFPEUHCYOS-UHFFFAOYSA-N 0.000 description 2
• OPBLMUCYLATNGT-UHFFFAOYSA-N n-(2-benzoylnaphthalen-1-yl)-3,5-dichlorobenzenesulfonamide Chemical compound ClC1=CC(Cl)=CC(S(=O)(=O)NC=2C3=CC=CC=C3C=CC=2C(=O)C=2C=CC=CC=2)=C1 OPBLMUCYLATNGT-UHFFFAOYSA-N 0.000 description 2
• QLADCDBPAJPWHO-UHFFFAOYSA-N n-[(4-cyanophenyl)methyl]-6-[(3,5-dichlorophenyl)sulfonylamino]naphthalene-1-carboxamide Chemical compound ClC1=CC(Cl)=CC(S(=O)(=O)NC=2C=C3C=CC=C(C3=CC=2)C(=O)NCC=2C=CC(=CC=2)C#N)=C1 QLADCDBPAJPWHO-UHFFFAOYSA-N 0.000 description 2
• MATDRTITUMPVOO-UHFFFAOYSA-N n-[bis(phenylmethoxy)phosphorylmethyl]-1,1,1-triphenylmethanamine Chemical compound C=1C=CC=CC=1COP(OCC=1C=CC=CC=1)(=O)CNC(C=1C=CC=CC=1)(C=1C=CC=CC=1)C1=CC=CC=C1 MATDRTITUMPVOO-UHFFFAOYSA-N 0.000 description 2
• CMWLCGVRRLPJAR-UHFFFAOYSA-N n-[bis(phenylmethoxy)phosphorylmethyl]-3,5-dichloro-n-naphthalen-2-ylbenzenesulfonamide Chemical compound ClC1=CC(Cl)=CC(S(=O)(=O)N(CP(=O)(OCC=2C=CC=CC=2)OCC=2C=CC=CC=2)C=2C=C3C=CC=CC3=CC=2)=C1 CMWLCGVRRLPJAR-UHFFFAOYSA-N 0.000 description 2
• NUWIVSAHKXUNQQ-UHFFFAOYSA-N n-[bis(phenylmethoxy)phosphorylmethyl]-3,5-dichlorobenzenesulfonamide Chemical compound ClC1=CC(Cl)=CC(S(=O)(=O)NCP(=O)(OCC=2C=CC=CC=2)OCC=2C=CC=CC=2)=C1 NUWIVSAHKXUNQQ-UHFFFAOYSA-N 0.000 description 2
• JRYNMFRRUPYCPC-UHFFFAOYSA-N n-benzyl-5-[(3,5-dichlorophenyl)sulfonyl-(diethoxyphosphorylmethyl)amino]naphthalene-1-carboxamide Chemical compound C=1C(Cl)=CC(Cl)=CC=1S(=O)(=O)N(CP(=O)(OCC)OCC)C(C1=CC=C2)=CC=CC1=C2C(=O)NCC1=CC=CC=C1 JRYNMFRRUPYCPC-UHFFFAOYSA-N 0.000 description 2
• AIAJGWZJBAEPSO-UHFFFAOYSA-N n-benzyl-6-[(3,5-dichlorophenyl)sulfonylamino]naphthalene-1-carboxamide Chemical compound ClC1=CC(Cl)=CC(S(=O)(=O)NC=2C=C3C=CC=C(C3=CC=2)C(=O)NCC=2C=CC=CC=2)=C1 AIAJGWZJBAEPSO-UHFFFAOYSA-N 0.000 description 2
• 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
• 125000001624 naphthyl group Chemical group 0.000 description 2
• LQNUZADURLCDLV-UHFFFAOYSA-N nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1 LQNUZADURLCDLV-UHFFFAOYSA-N 0.000 description 2
• 235000020824 obesity Nutrition 0.000 description 2
• NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 2
• 125000006340 pentafluoro ethyl group Chemical group FC(F)(F)C(F)(F)* 0.000 description 2
• 125000002255 pentenyl group Chemical group C(=CCCC)* 0.000 description 2
• 108091008725 peroxisome proliferator-activated receptors alpha Proteins 0.000 description 2
• 230000000144 pharmacologic effect Effects 0.000 description 2
• DGTNSSLYPYDJGL-UHFFFAOYSA-N phenyl isocyanate Chemical compound O=C=NC1=CC=CC=C1 DGTNSSLYPYDJGL-UHFFFAOYSA-N 0.000 description 2
• HYAFETHFCAUJAY-UHFFFAOYSA-N pioglitazone Chemical compound N1=CC(CC)=CC=C1CCOC(C=C1)=CC=C1CC1C(=O)NC(=O)S1 HYAFETHFCAUJAY-UHFFFAOYSA-N 0.000 description 2
• 125000004193 piperazinyl group Chemical group 0.000 description 2
• 125000003386 piperidinyl group Chemical group 0.000 description 2
• 229920001223 polyethylene glycol Polymers 0.000 description 2
• 239000000843 powder Substances 0.000 description 2
• 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
• 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 2
• 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 2
• QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
• 125000000719 pyrrolidinyl group Chemical group 0.000 description 2
• 238000012552 review Methods 0.000 description 2
• 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
• 229910001958 silver carbonate Inorganic materials 0.000 description 2
• LKZMBDSASOBTPN-UHFFFAOYSA-L silver carbonate Substances [Ag].[O-]C([O-])=O LKZMBDSASOBTPN-UHFFFAOYSA-L 0.000 description 2
• 239000011780 sodium chloride Substances 0.000 description 2
• LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 2
• 239000007858 starting material Substances 0.000 description 2
• 230000006103 sulfonylation Effects 0.000 description 2
• 238000005694 sulfonylation reaction Methods 0.000 description 2
• YBBRCQOCSYXUOC-UHFFFAOYSA-N sulfuryl dichloride Chemical compound ClS(Cl)(=O)=O YBBRCQOCSYXUOC-UHFFFAOYSA-N 0.000 description 2
• 239000007916 tablet composition Substances 0.000 description 2
• RMMXLENWKUUMAY-UHFFFAOYSA-N telmisartan Chemical compound CCCC1=NC2=C(C)C=C(C=3N(C4=CC=CC=C4N=3)C)C=C2N1CC(C=C1)=CC=C1C1=CC=CC=C1C(O)=O RMMXLENWKUUMAY-UHFFFAOYSA-N 0.000 description 2
• FPGGTKZVZWFYPV-UHFFFAOYSA-M tetrabutylammonium fluoride Chemical compound [F-].CCCC[N+](CCCC)(CCCC)CCCC FPGGTKZVZWFYPV-UHFFFAOYSA-M 0.000 description 2
• VEPTXBCIDSFGBF-UHFFFAOYSA-M tetrabutylazanium;fluoride;trihydrate Chemical compound O.O.O.[F-].CCCC[N+](CCCC)(CCCC)CCCC VEPTXBCIDSFGBF-UHFFFAOYSA-M 0.000 description 2
• 125000003718 tetrahydrofuranyl group Chemical group 0.000 description 2
• QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 2
• QAEDZJGFFMLHHQ-UHFFFAOYSA-N trifluoroacetic anhydride Chemical compound FC(F)(F)C(=O)OC(=O)C(F)(F)F QAEDZJGFFMLHHQ-UHFFFAOYSA-N 0.000 description 2
• 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 2
• 229940075966 (+)- menthol Drugs 0.000 description 1
• DBGIVFWFUFKIQN-VIFPVBQESA-N (+)-Fenfluramine Chemical compound CCN[C@@H](C)CC1=CC=CC(C(F)(F)F)=C1 DBGIVFWFUFKIQN-VIFPVBQESA-N 0.000 description 1
• NOOLISFMXDJSKH-AEJSXWLSSA-N (+)-menthol Chemical compound CC(C)[C@H]1CC[C@H](C)C[C@@H]1O NOOLISFMXDJSKH-AEJSXWLSSA-N 0.000 description 1
• FKPOFPSUEPTJCZ-UHFFFAOYSA-N (1-aminonaphthalen-2-yl)-pyrrolidin-1-ylmethanone Chemical compound C1=CC2=CC=CC=C2C(N)=C1C(=O)N1CCCC1 FKPOFPSUEPTJCZ-UHFFFAOYSA-N 0.000 description 1
• QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 1
• XUFXOAAUWZOOIT-SXARVLRPSA-N (2R,3R,4R,5S,6R)-5-[[(2R,3R,4R,5S,6R)-5-[[(2R,3R,4S,5S,6R)-3,4-dihydroxy-6-methyl-5-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-1-cyclohex-2-enyl]amino]-2-oxanyl]oxy]-3,4-dihydroxy-6-(hydroxymethyl)-2-oxanyl]oxy]-6-(hydroxymethyl)oxane-2,3,4-triol Chemical compound O([C@H]1O[C@H](CO)[C@H]([C@@H]([C@H]1O)O)O[C@H]1O[C@@H]([C@H]([C@H](O)[C@H]1O)N[C@@H]1[C@@H]([C@@H](O)[C@H](O)C(CO)=C1)O)C)[C@@H]1[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]1O XUFXOAAUWZOOIT-SXARVLRPSA-N 0.000 description 1
• AAWZDTNXLSGCEK-LNVDRNJUSA-N (3r,5r)-1,3,4,5-tetrahydroxycyclohexane-1-carboxylic acid Chemical compound O[C@@H]1CC(O)(C(O)=O)C[C@@H](O)C1O AAWZDTNXLSGCEK-LNVDRNJUSA-N 0.000 description 1
• 125000004169 (C1-C6) alkyl group Chemical group 0.000 description 1
• MIOPJNTWMNEORI-GMSGAONNSA-N (S)-camphorsulfonic acid Chemical compound C1C[C@@]2(CS(O)(=O)=O)C(=O)C[C@@H]1C2(C)C MIOPJNTWMNEORI-GMSGAONNSA-N 0.000 description 1
• BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
• KZPYGQFFRCFCPP-UHFFFAOYSA-N 1,1'-bis(diphenylphosphino)ferrocene Chemical compound [Fe+2].C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1 KZPYGQFFRCFCPP-UHFFFAOYSA-N 0.000 description 1
• FKTXDTWDCPTPHK-UHFFFAOYSA-N 1,1,1,2,3,3,3-heptafluoropropane Chemical group FC(F)(F)[C](F)C(F)(F)F FKTXDTWDCPTPHK-UHFFFAOYSA-N 0.000 description 1
• SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 1
• 125000005988 1,1-dioxo-thiomorpholinyl group Chemical group 0.000 description 1
• CSNIZNHTOVFARY-UHFFFAOYSA-N 1,2-benzothiazole Chemical compound C1=CC=C2C=NSC2=C1 CSNIZNHTOVFARY-UHFFFAOYSA-N 0.000 description 1
• BCMCBBGGLRIHSE-UHFFFAOYSA-N 1,3-benzoxazole Chemical compound C1=CC=C2OC=NC2=C1 BCMCBBGGLRIHSE-UHFFFAOYSA-N 0.000 description 1
• GAVVXPGGEDOQCH-UHFFFAOYSA-N 1-(5-aminonaphthalen-1-yl)-3-phenylurea Chemical compound C1=CC=C2C(N)=CC=CC2=C1NC(=O)NC1=CC=CC=C1 GAVVXPGGEDOQCH-UHFFFAOYSA-N 0.000 description 1
• MMCYEYMYHWUPJO-UHFFFAOYSA-N 1-[(3,5-dichlorophenyl)sulfonyl-(diethoxyphosphorylmethyl)amino]-n'-hydroxynaphthalene-2-carboximidamide Chemical compound ONC(=N)C=1C=CC2=CC=CC=C2C=1N(CP(=O)(OCC)OCC)S(=O)(=O)C1=CC(Cl)=CC(Cl)=C1 MMCYEYMYHWUPJO-UHFFFAOYSA-N 0.000 description 1
• YIDRKKWLSZGAEF-UHFFFAOYSA-N 1-[(3,5-dichlorophenyl)sulfonyl-(diethoxyphosphorylmethyl)amino]-n,n-dimethylnaphthalene-2-carboxamide Chemical compound CN(C)C(=O)C=1C=CC2=CC=CC=C2C=1N(CP(=O)(OCC)OCC)S(=O)(=O)C1=CC(Cl)=CC(Cl)=C1 YIDRKKWLSZGAEF-UHFFFAOYSA-N 0.000 description 1
• CBBQKZFEJIHUJT-UHFFFAOYSA-N 1-[(3,5-dichlorophenyl)sulfonyl-(diethoxyphosphorylmethyl)amino]naphthalene-2-carboxamide Chemical compound NC(=O)C=1C=CC2=CC=CC=C2C=1N(CP(=O)(OCC)OCC)S(=O)(=O)C1=CC(Cl)=CC(Cl)=C1 CBBQKZFEJIHUJT-UHFFFAOYSA-N 0.000 description 1
• GVSDMFSVVOQHEQ-UHFFFAOYSA-N 1-[(3,5-dichlorophenyl)sulfonylamino]-n,n-dimethylnaphthalene-2-carboxamide Chemical compound CN(C)C(=O)C1=CC=C2C=CC=CC2=C1NS(=O)(=O)C1=CC(Cl)=CC(Cl)=C1 GVSDMFSVVOQHEQ-UHFFFAOYSA-N 0.000 description 1
• JKZWBGVMZGIWOC-UHFFFAOYSA-N 1-[5-[(3,5-dichlorophenyl)sulfonyl-(diethoxyphosphorylmethyl)amino]naphthalen-1-yl]-3-phenylurea Chemical compound C=1C(Cl)=CC(Cl)=CC=1S(=O)(=O)N(CP(=O)(OCC)OCC)C(C1=CC=C2)=CC=CC1=C2NC(=O)NC1=CC=CC=C1 JKZWBGVMZGIWOC-UHFFFAOYSA-N 0.000 description 1
• XTZMDCIQABAWIV-UHFFFAOYSA-N 1-[5-[(3,5-dichlorophenyl)sulfonylamino]naphthalen-1-yl]-3-phenylurea Chemical compound ClC1=CC(Cl)=CC(S(=O)(=O)NC=2C3=CC=CC(NC(=O)NC=4C=CC=CC=4)=C3C=CC=2)=C1 XTZMDCIQABAWIV-UHFFFAOYSA-N 0.000 description 1
• SNRJPARZWNREMI-UHFFFAOYSA-N 1-[6-[(3,5-dichlorophenyl)sulfonyl-(diethoxyphosphorylmethyl)amino]naphthalen-2-yl]-3-phenylurea Chemical compound C=1C(Cl)=CC(Cl)=CC=1S(=O)(=O)N(CP(=O)(OCC)OCC)C(C=C1C=C2)=CC=C1C=C2NC(=O)NC1=CC=CC=C1 SNRJPARZWNREMI-UHFFFAOYSA-N 0.000 description 1
• VKHHGVDBIYMZPB-UHFFFAOYSA-N 1-amino-n,n-dimethylnaphthalene-2-carboxamide Chemical compound C1=CC=CC2=C(N)C(C(=O)N(C)C)=CC=C21 VKHHGVDBIYMZPB-UHFFFAOYSA-N 0.000 description 1
• NUJOMNGKEKQPDU-UHFFFAOYSA-N 1-amino-n-benzylnaphthalene-2-carboxamide Chemical compound C1=CC2=CC=CC=C2C(N)=C1C(=O)NCC1=CC=CC=C1 NUJOMNGKEKQPDU-UHFFFAOYSA-N 0.000 description 1
• 125000004973 1-butenyl group Chemical group C(=CCC)* 0.000 description 1
• DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 description 1
• 125000004972 1-butynyl group Chemical group [H]C([H])([H])C([H])([H])C#C* 0.000 description 1
• 125000006019 1-methyl-1-propenyl group Chemical group 0.000 description 1
• 125000006021 1-methyl-2-propenyl group Chemical group 0.000 description 1
• AVFZOVWCLRSYKC-UHFFFAOYSA-N 1-methylpyrrolidine Chemical compound CN1CCCC1 AVFZOVWCLRSYKC-UHFFFAOYSA-N 0.000 description 1
• 125000005987 1-oxo-thiomorpholinyl group Chemical group 0.000 description 1
• 125000006017 1-propenyl group Chemical group 0.000 description 1
• 125000000530 1-propynyl group Chemical group [H]C([H])([H])C#C* 0.000 description 1
• 238000005160 1H NMR spectroscopy Methods 0.000 description 1
• HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical compound C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 description 1
• BAXOFTOLAUCFNW-UHFFFAOYSA-N 1H-indazole Chemical compound C1=CC=C2C=NNC2=C1 BAXOFTOLAUCFNW-UHFFFAOYSA-N 0.000 description 1
• URARCPJGCZTHHZ-UHFFFAOYSA-N 1h-benzo[h][3,1]benzoxazine-2,4-dione Chemical compound C1=CC=CC2=CC=C(C(=O)OC(=O)N3)C3=C21 URARCPJGCZTHHZ-UHFFFAOYSA-N 0.000 description 1
• KMGUEILFFWDGFV-UHFFFAOYSA-N 2-benzoyl-2-benzoyloxy-3-hydroxybutanedioic acid Chemical compound C=1C=CC=CC=1C(=O)C(C(C(O)=O)O)(C(O)=O)OC(=O)C1=CC=CC=C1 KMGUEILFFWDGFV-UHFFFAOYSA-N 0.000 description 1
• PGFIHORVILKHIA-UHFFFAOYSA-N 2-bromopyrimidine Chemical compound BrC1=NC=CC=N1 PGFIHORVILKHIA-UHFFFAOYSA-N 0.000 description 1
• 125000004974 2-butenyl group Chemical group C(C=CC)* 0.000 description 1
• 125000000069 2-butynyl group Chemical group [H]C([H])([H])C#CC([H])([H])* 0.000 description 1
• WUEAMTVQNGYLRI-UHFFFAOYSA-N 2-dichlorophosphoryl-1,3,5-tri(propan-2-yl)benzene Chemical compound CC(C)C1=CC(C(C)C)=C(P(Cl)(Cl)=O)C(C(C)C)=C1 WUEAMTVQNGYLRI-UHFFFAOYSA-N 0.000 description 1
• NOLFSWQWHXNNKA-UHFFFAOYSA-N 2-iodonaphthalen-1-amine Chemical compound C1=CC=C2C(N)=C(I)C=CC2=C1 NOLFSWQWHXNNKA-UHFFFAOYSA-N 0.000 description 1
• 125000004638 2-oxopiperazinyl group Chemical group O=C1N(CCNC1)* 0.000 description 1
• VMZCDNSFRSVYKQ-UHFFFAOYSA-N 2-phenylacetyl chloride Chemical compound ClC(=O)CC1=CC=CC=C1 VMZCDNSFRSVYKQ-UHFFFAOYSA-N 0.000 description 1
• 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
• 125000001494 2-propynyl group Chemical group [H]C#CC([H])([H])* 0.000 description 1
• VHMICKWLTGFITH-UHFFFAOYSA-N 2H-isoindole Chemical compound C1=CC=CC2=CNC=C21 VHMICKWLTGFITH-UHFFFAOYSA-N 0.000 description 1
• GQAFOMIWNWXHEK-UHFFFAOYSA-N 3,5-dibromo-n-(diethoxyphosphorylmethyl)-n-naphthalen-1-ylbenzenesulfonamide Chemical compound C=1C=CC2=CC=CC=C2C=1N(CP(=O)(OCC)OCC)S(=O)(=O)C1=CC(Br)=CC(Br)=C1 GQAFOMIWNWXHEK-UHFFFAOYSA-N 0.000 description 1
• GEFNNLUMKUJFNI-UHFFFAOYSA-N 3,5-dibromo-n-naphthalen-1-ylbenzenesulfonamide Chemical compound BrC1=CC(Br)=CC(S(=O)(=O)NC=2C3=CC=CC=C3C=CC=2)=C1 GEFNNLUMKUJFNI-UHFFFAOYSA-N 0.000 description 1
• ZZKRUDSKIQRSMX-UHFFFAOYSA-N 3,5-dichloro-4-fluoro-n-naphthalen-1-ylbenzenesulfonamide Chemical compound C1=C(Cl)C(F)=C(Cl)C=C1S(=O)(=O)NC1=CC=CC2=CC=CC=C12 ZZKRUDSKIQRSMX-UHFFFAOYSA-N 0.000 description 1
• DVAHBTCBQASAHZ-UHFFFAOYSA-N 3,5-dichloro-4-fluorobenzenesulfonyl chloride Chemical compound FC1=C(Cl)C=C(S(Cl)(=O)=O)C=C1Cl DVAHBTCBQASAHZ-UHFFFAOYSA-N 0.000 description 1
• PAGRKPXSPUGLKS-UHFFFAOYSA-N 3,5-dichloro-n-(2-chloronaphthalen-1-yl)-n-(diethoxyphosphorylmethyl)benzenesulfonamide Chemical compound ClC=1C=CC2=CC=CC=C2C=1N(CP(=O)(OCC)OCC)S(=O)(=O)C1=CC(Cl)=CC(Cl)=C1 PAGRKPXSPUGLKS-UHFFFAOYSA-N 0.000 description 1
• LAOHVJMVSKGUDI-UHFFFAOYSA-N 3,5-dichloro-n-(2-chloronaphthalen-1-yl)benzenesulfonamide Chemical compound ClC1=CC(Cl)=CC(S(=O)(=O)NC=2C3=CC=CC=C3C=CC=2Cl)=C1 LAOHVJMVSKGUDI-UHFFFAOYSA-N 0.000 description 1
• CNCBTXQSHAELPI-UHFFFAOYSA-N 3,5-dichloro-n-(2-cyanonaphthalen-1-yl)-n-(diethoxyphosphorylmethyl)benzenesulfonamide Chemical compound N#CC=1C=CC2=CC=CC=C2C=1N(CP(=O)(OCC)OCC)S(=O)(=O)C1=CC(Cl)=CC(Cl)=C1 CNCBTXQSHAELPI-UHFFFAOYSA-N 0.000 description 1
• HQLWTVUZGXTHJV-UHFFFAOYSA-N 3,5-dichloro-n-(2-cyanonaphthalen-1-yl)benzenesulfonamide Chemical compound ClC1=CC(Cl)=CC(S(=O)(=O)NC=2C3=CC=CC=C3C=CC=2C#N)=C1 HQLWTVUZGXTHJV-UHFFFAOYSA-N 0.000 description 1
• XHWWPLRBDFJKAT-UHFFFAOYSA-N 3,5-dichloro-n-(2-methoxynaphthalen-1-yl)benzenesulfonamide Chemical compound COC1=CC=C2C=CC=CC2=C1NS(=O)(=O)C1=CC(Cl)=CC(Cl)=C1 XHWWPLRBDFJKAT-UHFFFAOYSA-N 0.000 description 1
• VCHOKVGMNLLIRB-UHFFFAOYSA-N 3,5-dichloro-n-(2-methylnaphthalen-1-yl)benzenesulfonamide Chemical compound CC1=CC=C2C=CC=CC2=C1NS(=O)(=O)C1=CC(Cl)=CC(Cl)=C1 VCHOKVGMNLLIRB-UHFFFAOYSA-N 0.000 description 1
• NNZBWSXORSAKMN-UHFFFAOYSA-N 3,5-dichloro-n-(2-methylquinolin-8-yl)benzenesulfonamide Chemical compound C12=NC(C)=CC=C2C=CC=C1NS(=O)(=O)C1=CC(Cl)=CC(Cl)=C1 NNZBWSXORSAKMN-UHFFFAOYSA-N 0.000 description 1
• TVOJHWNHODMFBE-UHFFFAOYSA-N 3,5-dichloro-n-(3-methylcinnolin-5-yl)benzenesulfonamide Chemical compound C1=CC=C2N=NC(C)=CC2=C1NS(=O)(=O)C1=CC(Cl)=CC(Cl)=C1 TVOJHWNHODMFBE-UHFFFAOYSA-N 0.000 description 1
• GYBYSLZSCPDOTM-UHFFFAOYSA-N 3,5-dichloro-n-(3-methylisoquinolin-5-yl)benzenesulfonamide Chemical compound C1=CC=C2C=NC(C)=CC2=C1NS(=O)(=O)C1=CC(Cl)=CC(Cl)=C1 GYBYSLZSCPDOTM-UHFFFAOYSA-N 0.000 description 1
• FAUPJNUQODEFAW-UHFFFAOYSA-N 3,5-dichloro-n-(3-methylnaphthalen-2-yl)benzenesulfonamide Chemical compound CC1=CC2=CC=CC=C2C=C1NS(=O)(=O)C1=CC(Cl)=CC(Cl)=C1 FAUPJNUQODEFAW-UHFFFAOYSA-N 0.000 description 1
• GUQYQBWHLADKGL-UHFFFAOYSA-N 3,5-dichloro-n-(3-methylquinolin-5-yl)benzenesulfonamide Chemical compound C12=CC(C)=CN=C2C=CC=C1NS(=O)(=O)C1=CC(Cl)=CC(Cl)=C1 GUQYQBWHLADKGL-UHFFFAOYSA-N 0.000 description 1
• ALDCJNOVINDPSU-UHFFFAOYSA-N 3,5-dichloro-n-(4-methoxynaphthalen-1-yl)benzenesulfonamide Chemical compound C12=CC=CC=C2C(OC)=CC=C1NS(=O)(=O)C1=CC(Cl)=CC(Cl)=C1 ALDCJNOVINDPSU-UHFFFAOYSA-N 0.000 description 1
• QVTYZKYOCPFRJV-UHFFFAOYSA-N 3,5-dichloro-n-(5-cyanonaphthalen-1-yl)-n-(diethoxyphosphorylmethyl)benzenesulfonamide Chemical compound C=1C=CC2=C(C#N)C=CC=C2C=1N(CP(=O)(OCC)OCC)S(=O)(=O)C1=CC(Cl)=CC(Cl)=C1 QVTYZKYOCPFRJV-UHFFFAOYSA-N 0.000 description 1
• IPNFQNDXMCEZFO-UHFFFAOYSA-N 3,5-dichloro-n-(5-cyanonaphthalen-1-yl)benzenesulfonamide Chemical compound ClC1=CC(Cl)=CC(S(=O)(=O)NC=2C3=CC=CC(=C3C=CC=2)C#N)=C1 IPNFQNDXMCEZFO-UHFFFAOYSA-N 0.000 description 1
• OOLRHGXBSVCXKW-UHFFFAOYSA-N 3,5-dichloro-n-(5-methoxynaphthalen-1-yl)benzenesulfonamide Chemical compound C1=CC=C2C(OC)=CC=CC2=C1NS(=O)(=O)C1=CC(Cl)=CC(Cl)=C1 OOLRHGXBSVCXKW-UHFFFAOYSA-N 0.000 description 1
• UQPSCKPVYXJFBP-UHFFFAOYSA-N 3,5-dichloro-n-(6-pyrimidin-2-ylnaphthalen-2-yl)benzenesulfonamide Chemical compound ClC1=CC(Cl)=CC(S(=O)(=O)NC=2C=C3C=CC(=CC3=CC=2)C=2N=CC=CN=2)=C1 UQPSCKPVYXJFBP-UHFFFAOYSA-N 0.000 description 1
• HWTILXHVSZJLNB-UHFFFAOYSA-N 3,5-dichloro-n-(7-methylquinolin-8-yl)benzenesulfonamide Chemical compound CC1=CC=C2C=CC=NC2=C1NS(=O)(=O)C1=CC(Cl)=CC(Cl)=C1 HWTILXHVSZJLNB-UHFFFAOYSA-N 0.000 description 1
• IGHRTLDYFGZDKF-UHFFFAOYSA-N 3,5-dichloro-n-(diethoxyphosphorylmethyl)-4-fluoro-n-naphthalen-1-ylbenzenesulfonamide Chemical compound C=1C=CC2=CC=CC=C2C=1N(CP(=O)(OCC)OCC)S(=O)(=O)C1=CC(Cl)=C(F)C(Cl)=C1 IGHRTLDYFGZDKF-UHFFFAOYSA-N 0.000 description 1
• XWKUGDSAARVDRD-UHFFFAOYSA-N 3,5-dichloro-n-(diethoxyphosphorylmethyl)-n-(2-methoxynaphthalen-1-yl)benzenesulfonamide Chemical compound COC=1C=CC2=CC=CC=C2C=1N(CP(=O)(OCC)OCC)S(=O)(=O)C1=CC(Cl)=CC(Cl)=C1 XWKUGDSAARVDRD-UHFFFAOYSA-N 0.000 description 1
• BCWHDDTVCNMZIX-UHFFFAOYSA-N 3,5-dichloro-n-(diethoxyphosphorylmethyl)-n-(2-methylnaphthalen-1-yl)benzenesulfonamide Chemical compound CC=1C=CC2=CC=CC=C2C=1N(CP(=O)(OCC)OCC)S(=O)(=O)C1=CC(Cl)=CC(Cl)=C1 BCWHDDTVCNMZIX-UHFFFAOYSA-N 0.000 description 1
• UGWWQZZFTHUYRW-UHFFFAOYSA-N 3,5-dichloro-n-(diethoxyphosphorylmethyl)-n-(3-methylisoquinolin-5-yl)benzenesulfonamide Chemical compound C=1C=CC2=CN=C(C)C=C2C=1N(CP(=O)(OCC)OCC)S(=O)(=O)C1=CC(Cl)=CC(Cl)=C1 UGWWQZZFTHUYRW-UHFFFAOYSA-N 0.000 description 1
• QFZACLIFALTTPC-UHFFFAOYSA-N 3,5-dichloro-n-(diethoxyphosphorylmethyl)-n-(3-methylnaphthalen-2-yl)benzenesulfonamide Chemical compound C=1C2=CC=CC=C2C=C(C)C=1N(CP(=O)(OCC)OCC)S(=O)(=O)C1=CC(Cl)=CC(Cl)=C1 QFZACLIFALTTPC-UHFFFAOYSA-N 0.000 description 1
• NKAGOQZBTNVITG-UHFFFAOYSA-N 3,5-dichloro-n-(diethoxyphosphorylmethyl)-n-(4-methoxynaphthalen-1-yl)benzenesulfonamide Chemical compound C=1C=C(OC)C2=CC=CC=C2C=1N(CP(=O)(OCC)OCC)S(=O)(=O)C1=CC(Cl)=CC(Cl)=C1 NKAGOQZBTNVITG-UHFFFAOYSA-N 0.000 description 1
• ANANTXPMLMOCGX-UHFFFAOYSA-N 3,5-dichloro-n-(diethoxyphosphorylmethyl)-n-(5-methoxynaphthalen-1-yl)benzenesulfonamide Chemical compound C=1C=CC2=C(OC)C=CC=C2C=1N(CP(=O)(OCC)OCC)S(=O)(=O)C1=CC(Cl)=CC(Cl)=C1 ANANTXPMLMOCGX-UHFFFAOYSA-N 0.000 description 1
• SXXWXWVKIISYMM-UHFFFAOYSA-N 3,5-dichloro-n-(diethoxyphosphorylmethyl)-n-(7-methylquinolin-8-yl)benzenesulfonamide Chemical compound CC=1C=CC2=CC=CN=C2C=1N(CP(=O)(OCC)OCC)S(=O)(=O)C1=CC(Cl)=CC(Cl)=C1 SXXWXWVKIISYMM-UHFFFAOYSA-N 0.000 description 1
• AHRSFCSNLDDYPK-UHFFFAOYSA-N 3,5-dichloro-n-(diethoxyphosphorylmethyl)-n-[2-(pyrrolidine-1-carbonyl)naphthalen-1-yl]benzenesulfonamide Chemical compound C=1C(Cl)=CC(Cl)=CC=1S(=O)(=O)N(CP(=O)(OCC)OCC)C(C1=CC=CC=C1C=C1)=C1C(=O)N1CCCC1 AHRSFCSNLDDYPK-UHFFFAOYSA-N 0.000 description 1
• PORYJENSXZNAQJ-UHFFFAOYSA-N 3,5-dichloro-n-(diethoxyphosphorylmethyl)-n-naphthalen-1-ylbenzenesulfonamide Chemical compound C=1C=CC2=CC=CC=C2C=1N(CP(=O)(OCC)OCC)S(=O)(=O)C1=CC(Cl)=CC(Cl)=C1 PORYJENSXZNAQJ-UHFFFAOYSA-N 0.000 description 1
• VZWCPTKGYQZQHN-UHFFFAOYSA-N 3,5-dichloro-n-(diethoxyphosphorylmethyl)-n-quinazolin-8-ylbenzenesulfonamide Chemical compound C=1C=CC2=CN=CN=C2C=1N(CP(=O)(OCC)OCC)S(=O)(=O)C1=CC(Cl)=CC(Cl)=C1 VZWCPTKGYQZQHN-UHFFFAOYSA-N 0.000 description 1
• BBOZTCJIDYEAQP-UHFFFAOYSA-N 3,5-dichloro-n-(diethoxyphosphorylmethyl)-n-quinolin-3-ylbenzenesulfonamide Chemical compound C=1N=C2C=CC=CC2=CC=1N(CP(=O)(OCC)OCC)S(=O)(=O)C1=CC(Cl)=CC(Cl)=C1 BBOZTCJIDYEAQP-UHFFFAOYSA-N 0.000 description 1
• GNJFULHUDLVXCG-UHFFFAOYSA-N 3,5-dichloro-n-(diethoxyphosphorylmethyl)-n-quinolin-5-ylbenzenesulfonamide Chemical compound C=1C=CC2=NC=CC=C2C=1N(CP(=O)(OCC)OCC)S(=O)(=O)C1=CC(Cl)=CC(Cl)=C1 GNJFULHUDLVXCG-UHFFFAOYSA-N 0.000 description 1
• JPTHKENKCSWCIJ-UHFFFAOYSA-N 3,5-dichloro-n-(diethoxyphosphorylmethyl)-n-quinolin-6-ylbenzenesulfonamide Chemical compound C=1C=C2N=CC=CC2=CC=1N(CP(=O)(OCC)OCC)S(=O)(=O)C1=CC(Cl)=CC(Cl)=C1 JPTHKENKCSWCIJ-UHFFFAOYSA-N 0.000 description 1
• IVZYKVHKTMXTKY-UHFFFAOYSA-N 3,5-dichloro-n-(diethoxyphosphorylmethyl)-n-quinolin-7-ylbenzenesulfonamide Chemical compound C=1C=C2C=CC=NC2=CC=1N(CP(=O)(OCC)OCC)S(=O)(=O)C1=CC(Cl)=CC(Cl)=C1 IVZYKVHKTMXTKY-UHFFFAOYSA-N 0.000 description 1
• NDHCGJOLCSYUGC-UHFFFAOYSA-N 3,5-dichloro-n-(diethoxyphosphorylmethyl)-n-quinolin-8-ylbenzenesulfonamide Chemical compound C=1C=CC2=CC=CN=C2C=1N(CP(=O)(OCC)OCC)S(=O)(=O)C1=CC(Cl)=CC(Cl)=C1 NDHCGJOLCSYUGC-UHFFFAOYSA-N 0.000 description 1
• VZNVNTHOLHOJTE-UHFFFAOYSA-N 3,5-dichloro-n-(diethoxyphosphorylmethyl)-n-quinoxalin-5-ylbenzenesulfonamide Chemical compound C=1C=CC2=NC=CN=C2C=1N(CP(=O)(OCC)OCC)S(=O)(=O)C1=CC(Cl)=CC(Cl)=C1 VZNVNTHOLHOJTE-UHFFFAOYSA-N 0.000 description 1
• ZIEGZJGRMFLAEC-UHFFFAOYSA-N 3,5-dichloro-n-(diethoxyphosphorylmethyl)-n-quinoxalin-6-ylbenzenesulfonamide Chemical compound C=1C=C2N=CC=NC2=CC=1N(CP(=O)(OCC)OCC)S(=O)(=O)C1=CC(Cl)=CC(Cl)=C1 ZIEGZJGRMFLAEC-UHFFFAOYSA-N 0.000 description 1
• WJHRJEGYNYXMCZ-UHFFFAOYSA-N 3,5-dichloro-n-(diethoxyphosphorylmethyl)benzenesulfonamide Chemical compound CCOP(=O)(OCC)CNS(=O)(=O)C1=CC(Cl)=CC(Cl)=C1 WJHRJEGYNYXMCZ-UHFFFAOYSA-N 0.000 description 1
• BXIQUCBGNORMIL-UHFFFAOYSA-N 3,5-dichloro-n-[2-(pyrrolidine-1-carbonyl)naphthalen-1-yl]benzenesulfonamide Chemical compound ClC1=CC(Cl)=CC(S(=O)(=O)NC=2C3=CC=CC=C3C=CC=2C(=O)N2CCCC2)=C1 BXIQUCBGNORMIL-UHFFFAOYSA-N 0.000 description 1
• NMQLDQSKRYKUMT-UHFFFAOYSA-N 3,5-dichloro-n-[4-(dimethylamino)quinazolin-8-yl]benzenesulfonamide Chemical compound C1=CC=C2C(N(C)C)=NC=NC2=C1NS(=O)(=O)C1=CC(Cl)=CC(Cl)=C1 NMQLDQSKRYKUMT-UHFFFAOYSA-N 0.000 description 1
• RTHBMOPXMFHEHQ-UHFFFAOYSA-N 3,5-dichloro-n-quinazolin-8-ylbenzenesulfonamide Chemical compound ClC1=CC(Cl)=CC(S(=O)(=O)NC=2C3=NC=NC=C3C=CC=2)=C1 RTHBMOPXMFHEHQ-UHFFFAOYSA-N 0.000 description 1
• JFJLWZPEAALLFJ-UHFFFAOYSA-N 3,5-dichloro-n-quinolin-3-ylbenzenesulfonamide Chemical compound ClC1=CC(Cl)=CC(S(=O)(=O)NC=2C=C3C=CC=CC3=NC=2)=C1 JFJLWZPEAALLFJ-UHFFFAOYSA-N 0.000 description 1
• IRZZKVLVAWJCRY-UHFFFAOYSA-N 3,5-dichloro-n-quinolin-5-ylbenzenesulfonamide Chemical compound ClC1=CC(Cl)=CC(S(=O)(=O)NC=2C3=CC=CN=C3C=CC=2)=C1 IRZZKVLVAWJCRY-UHFFFAOYSA-N 0.000 description 1
• LUJIGGZAAPVDSC-UHFFFAOYSA-N 3,5-dichloro-n-quinolin-7-ylbenzenesulfonamide Chemical compound ClC1=CC(Cl)=CC(S(=O)(=O)NC=2C=C3N=CC=CC3=CC=2)=C1 LUJIGGZAAPVDSC-UHFFFAOYSA-N 0.000 description 1
• QNMQYTLASPEQJH-UHFFFAOYSA-N 3,5-dichloro-n-quinolin-8-ylbenzenesulfonamide Chemical compound ClC1=CC(Cl)=CC(S(=O)(=O)NC=2C3=NC=CC=C3C=CC=2)=C1 QNMQYTLASPEQJH-UHFFFAOYSA-N 0.000 description 1
• WIRQYNUPSGUTFK-UHFFFAOYSA-N 3,5-dichloro-n-quinoxalin-5-ylbenzenesulfonamide Chemical compound ClC1=CC(Cl)=CC(S(=O)(=O)NC=2C3=NC=CN=C3C=CC=2)=C1 WIRQYNUPSGUTFK-UHFFFAOYSA-N 0.000 description 1
• JUDUVATWDDFLTC-UHFFFAOYSA-N 3,5-dichloro-n-quinoxalin-6-ylbenzenesulfonamide Chemical compound ClC1=CC(Cl)=CC(S(=O)(=O)NC=2C=C3N=CC=NC3=CC=2)=C1 JUDUVATWDDFLTC-UHFFFAOYSA-N 0.000 description 1
• HPEDJIGBZVZVGY-UHFFFAOYSA-N 3,5-dimethyl-n-naphthalen-1-ylbenzenesulfonamide Chemical compound CC1=CC(C)=CC(S(=O)(=O)NC=2C3=CC=CC=C3C=CC=2)=C1 HPEDJIGBZVZVGY-UHFFFAOYSA-N 0.000 description 1
• FZLAARFEJZTGAI-UHFFFAOYSA-N 3-amino-5-chloro-n-(diethoxyphosphorylmethyl)-n-naphthalen-1-ylbenzenesulfonamide Chemical compound C=1C=CC2=CC=CC=C2C=1N(CP(=O)(OCC)OCC)S(=O)(=O)C1=CC(N)=CC(Cl)=C1 FZLAARFEJZTGAI-UHFFFAOYSA-N 0.000 description 1
• BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
• TWGFZLSLNXVEEB-UHFFFAOYSA-N 3-bromo-5-chloro-n-(diethoxyphosphorylmethyl)-n-naphthalen-1-ylbenzenesulfonamide Chemical compound C=1C=CC2=CC=CC=C2C=1N(CP(=O)(OCC)OCC)S(=O)(=O)C1=CC(Cl)=CC(Br)=C1 TWGFZLSLNXVEEB-UHFFFAOYSA-N 0.000 description 1
• VYGRUORQPRNBJO-UHFFFAOYSA-N 3-bromo-5-chloro-n-naphthalen-1-ylbenzenesulfonamide Chemical compound ClC1=CC(Br)=CC(S(=O)(=O)NC=2C3=CC=CC=C3C=CC=2)=C1 VYGRUORQPRNBJO-UHFFFAOYSA-N 0.000 description 1
• TVNXVTHWGFPUFR-UHFFFAOYSA-N 3-bromo-5-chlorobenzenesulfonyl chloride Chemical compound ClC1=CC(Br)=CC(S(Cl)(=O)=O)=C1 TVNXVTHWGFPUFR-UHFFFAOYSA-N 0.000 description 1
• KNMPYIIICYDSLW-UHFFFAOYSA-N 3-bromo-5-methyl-n-naphthalen-1-ylbenzenesulfonamide Chemical compound CC1=CC(Br)=CC(S(=O)(=O)NC=2C3=CC=CC=C3C=CC=2)=C1 KNMPYIIICYDSLW-UHFFFAOYSA-N 0.000 description 1
• BSYSYHSTNHHVJL-UHFFFAOYSA-N 3-bromo-5-methylbenzenesulfonyl chloride Chemical compound CC1=CC(Br)=CC(S(Cl)(=O)=O)=C1 BSYSYHSTNHHVJL-UHFFFAOYSA-N 0.000 description 1
• CLBSNSZHIMURRN-UHFFFAOYSA-N 3-bromo-n-(diethoxyphosphorylmethyl)-5-methyl-n-naphthalen-1-ylbenzenesulfonamide Chemical compound C=1C=CC2=CC=CC=C2C=1N(CP(=O)(OCC)OCC)S(=O)(=O)C1=CC(C)=CC(Br)=C1 CLBSNSZHIMURRN-UHFFFAOYSA-N 0.000 description 1
• 125000004975 3-butenyl group Chemical group C(CC=C)* 0.000 description 1
• 125000000474 3-butynyl group Chemical group [H]C#CC([H])([H])C([H])([H])* 0.000 description 1
• JYUGVORTFRFETG-UHFFFAOYSA-N 3-chloro-5-(trifluoromethyl)benzenesulfonyl chloride Chemical compound FC(F)(F)C1=CC(Cl)=CC(S(Cl)(=O)=O)=C1 JYUGVORTFRFETG-UHFFFAOYSA-N 0.000 description 1
• OMAYKMUBLOBAPK-UHFFFAOYSA-N 3-chloro-5-cyano-n-(diethoxyphosphorylmethyl)-n-naphthalen-1-ylbenzenesulfonamide Chemical compound C=1C=CC2=CC=CC=C2C=1N(CP(=O)(OCC)OCC)S(=O)(=O)C1=CC(Cl)=CC(C#N)=C1 OMAYKMUBLOBAPK-UHFFFAOYSA-N 0.000 description 1
• SHASXJIDKRLKRD-UHFFFAOYSA-N 3-chloro-5-cyano-n-naphthalen-1-ylbenzenesulfonamide Chemical compound ClC1=CC(C#N)=CC(S(=O)(=O)NC=2C3=CC=CC=C3C=CC=2)=C1 SHASXJIDKRLKRD-UHFFFAOYSA-N 0.000 description 1
• NNCVCCCUFMTMRO-UHFFFAOYSA-N 3-chloro-5-cyanobenzenesulfonyl chloride Chemical compound ClC1=CC(C#N)=CC(S(Cl)(=O)=O)=C1 NNCVCCCUFMTMRO-UHFFFAOYSA-N 0.000 description 1
• KJVXSVVVGPZXLZ-UHFFFAOYSA-N 3-chloro-5-fluoro-n-naphthalen-1-ylbenzenesulfonamide Chemical compound FC1=CC(Cl)=CC(S(=O)(=O)NC=2C3=CC=CC=C3C=CC=2)=C1 KJVXSVVVGPZXLZ-UHFFFAOYSA-N 0.000 description 1
• DMJUAPPEXOKHSW-UHFFFAOYSA-N 3-chloro-5-fluorobenzenesulfonyl chloride Chemical compound FC1=CC(Cl)=CC(S(Cl)(=O)=O)=C1 DMJUAPPEXOKHSW-UHFFFAOYSA-N 0.000 description 1
• RSPUGQCYCBDVOO-UHFFFAOYSA-N 3-chloro-5-methyl-n-naphthalen-1-ylbenzenesulfonamide Chemical compound CC1=CC(Cl)=CC(S(=O)(=O)NC=2C3=CC=CC=C3C=CC=2)=C1 RSPUGQCYCBDVOO-UHFFFAOYSA-N 0.000 description 1
• XUZCJDBXXYJXDD-UHFFFAOYSA-N 3-chloro-5-methylaniline Chemical compound CC1=CC(N)=CC(Cl)=C1 XUZCJDBXXYJXDD-UHFFFAOYSA-N 0.000 description 1
• XEUCFELODGWVMQ-UHFFFAOYSA-N 3-chloro-5-methylbenzenesulfonyl chloride Chemical compound CC1=CC(Cl)=CC(S(Cl)(=O)=O)=C1 XEUCFELODGWVMQ-UHFFFAOYSA-N 0.000 description 1
• WYILGLSXXCOVKO-UHFFFAOYSA-N 3-chloro-5-nitrobenzenesulfonyl chloride Chemical compound [O-][N+](=O)C1=CC(Cl)=CC(S(Cl)(=O)=O)=C1 WYILGLSXXCOVKO-UHFFFAOYSA-N 0.000 description 1
• VERFIYXMCAZTBT-UHFFFAOYSA-N 3-chloro-n-(diethoxyphosphorylmethyl)-5-fluoro-n-naphthalen-1-ylbenzenesulfonamide Chemical compound C=1C=CC2=CC=CC=C2C=1N(CP(=O)(OCC)OCC)S(=O)(=O)C1=CC(F)=CC(Cl)=C1 VERFIYXMCAZTBT-UHFFFAOYSA-N 0.000 description 1
• ANLTUMKNIGZYNU-UHFFFAOYSA-N 3-chloro-n-(diethoxyphosphorylmethyl)-5-methyl-n-naphthalen-1-ylbenzenesulfonamide Chemical compound C=1C=CC2=CC=CC=C2C=1N(CP(=O)(OCC)OCC)S(=O)(=O)C1=CC(C)=CC(Cl)=C1 ANLTUMKNIGZYNU-UHFFFAOYSA-N 0.000 description 1
• KRPSUAJHMSCEQE-UHFFFAOYSA-N 3-chloro-n-(diethoxyphosphorylmethyl)-n-naphthalen-1-yl-5-(trifluoromethyl)benzenesulfonamide Chemical compound C=1C=CC2=CC=CC=C2C=1N(CP(=O)(OCC)OCC)S(=O)(=O)C1=CC(Cl)=CC(C(F)(F)F)=C1 KRPSUAJHMSCEQE-UHFFFAOYSA-N 0.000 description 1
• HEGMGYYCAHQOOC-UHFFFAOYSA-N 3-chloro-n-naphthalen-1-yl-5-(trifluoromethyl)benzenesulfonamide Chemical compound FC(F)(F)C1=CC(Cl)=CC(S(=O)(=O)NC=2C3=CC=CC=C3C=CC=2)=C1 HEGMGYYCAHQOOC-UHFFFAOYSA-N 0.000 description 1
• YCVXNXYIJCBBRS-UHFFFAOYSA-N 3-chloro-n-naphthalen-1-yl-5-nitrobenzenesulfonamide Chemical compound [O-][N+](=O)C1=CC(Cl)=CC(S(=O)(=O)NC=2C3=CC=CC=C3C=CC=2)=C1 YCVXNXYIJCBBRS-UHFFFAOYSA-N 0.000 description 1
• 239000003148 4 aminobutyric acid receptor blocking agent Substances 0.000 description 1
• YNIKQCKETYIRTH-UHFFFAOYSA-N 4-chloro-8-nitroquinazoline Chemical compound N1=CN=C2C([N+](=O)[O-])=CC=CC2=C1Cl YNIKQCKETYIRTH-UHFFFAOYSA-N 0.000 description 1
• 125000002373 5 membered heterocyclic group Chemical group 0.000 description 1
• 102000006902 5-HT2C Serotonin Receptor Human genes 0.000 description 1
• NFFXEUUOMTXWCX-UHFFFAOYSA-N 5-[(2,4-dioxo-1,3-thiazolidin-5-yl)methyl]-2-methoxy-n-[[4-(trifluoromethyl)phenyl]methyl]benzamide Chemical compound C1=C(C(=O)NCC=2C=CC(=CC=2)C(F)(F)F)C(OC)=CC=C1CC1SC(=O)NC1=O NFFXEUUOMTXWCX-UHFFFAOYSA-N 0.000 description 1
• VBGKDDOGVSBOQH-UHFFFAOYSA-N 5-[(3,5-dichlorophenyl)sulfonyl-(diethoxyphosphorylmethyl)amino]-n'-hydroxynaphthalene-1-carboximidamide Chemical compound C=1C=CC2=C(C(=N)NO)C=CC=C2C=1N(CP(=O)(OCC)OCC)S(=O)(=O)C1=CC(Cl)=CC(Cl)=C1 VBGKDDOGVSBOQH-UHFFFAOYSA-N 0.000 description 1
• VBHNCARKIQLEFT-UHFFFAOYSA-N 5-[(3,5-dichlorophenyl)sulfonyl-(diethoxyphosphorylmethyl)amino]-n,n-dimethylnaphthalene-1-sulfonamide Chemical compound C=1C=CC2=C(S(=O)(=O)N(C)C)C=CC=C2C=1N(CP(=O)(OCC)OCC)S(=O)(=O)C1=CC(Cl)=CC(Cl)=C1 VBHNCARKIQLEFT-UHFFFAOYSA-N 0.000 description 1
• NGWINIGWMNNPRO-UHFFFAOYSA-N 5-[(3,5-dichlorophenyl)sulfonyl-(diethoxyphosphorylmethyl)amino]-n-(2-phenylethyl)naphthalene-1-carboxamide Chemical compound C=1C(Cl)=CC(Cl)=CC=1S(=O)(=O)N(CP(=O)(OCC)OCC)C(C1=CC=C2)=CC=CC1=C2C(=O)NCCC1=CC=CC=C1 NGWINIGWMNNPRO-UHFFFAOYSA-N 0.000 description 1
• VVGZRLWJWFKYRX-UHFFFAOYSA-N 5-[(3,5-dichlorophenyl)sulfonylamino]-n,n-dimethylnaphthalene-1-sulfonamide Chemical compound C1=CC=C2C(S(=O)(=O)N(C)C)=CC=CC2=C1NS(=O)(=O)C1=CC(Cl)=CC(Cl)=C1 VVGZRLWJWFKYRX-UHFFFAOYSA-N 0.000 description 1
• GVLDCBDYUZRYRI-UHFFFAOYSA-N 5-[(3,5-dichlorophenyl)sulfonylamino]-n-(2-phenylethyl)naphthalene-1-carboxamide Chemical compound ClC1=CC(Cl)=CC(S(=O)(=O)NC=2C3=CC=CC(=C3C=CC=2)C(=O)NCCC=2C=CC=CC=2)=C1 GVLDCBDYUZRYRI-UHFFFAOYSA-N 0.000 description 1
• YKTDNMQYGNUJFZ-UHFFFAOYSA-N 5-bromo-n'-hydroxynaphthalene-2-carboximidamide Chemical compound BrC1=CC=CC2=CC(C(=N)NO)=CC=C21 YKTDNMQYGNUJFZ-UHFFFAOYSA-N 0.000 description 1
• IMVDZFOSXJSXFP-UHFFFAOYSA-N 5-chloro-2-propyl-3-[[4-[2-(2h-tetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carbaldehyde Chemical compound CCCC1=NC(Cl)=C(C=O)N1CC1=CC=C(C=2C(=CC=CC=2)C2=NNN=N2)C=C1 IMVDZFOSXJSXFP-UHFFFAOYSA-N 0.000 description 1
• 125000004070 6 membered heterocyclic group Chemical group 0.000 description 1
• XVMSFILGAMDHEY-UHFFFAOYSA-N 6-(4-aminophenyl)sulfonylpyridin-3-amine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC=C(N)C=N1 XVMSFILGAMDHEY-UHFFFAOYSA-N 0.000 description 1
• QPGBFTLLSFJFMR-UHFFFAOYSA-N 6-[(3,5-dichlorophenyl)sulfonyl-(diethoxyphosphorylmethyl)amino]-n-methylnaphthalene-1-carboxamide Chemical compound C=1C=C2C(C(=O)NC)=CC=CC2=CC=1N(CP(=O)(OCC)OCC)S(=O)(=O)C1=CC(Cl)=CC(Cl)=C1 QPGBFTLLSFJFMR-UHFFFAOYSA-N 0.000 description 1
• RSNYLYQFWNZEBB-UHFFFAOYSA-N 6-[(3,5-dichlorophenyl)sulfonylamino]-n-methylnaphthalene-1-carboxamide Chemical compound C=1C=C2C(C(=O)NC)=CC=CC2=CC=1NS(=O)(=O)C1=CC(Cl)=CC(Cl)=C1 RSNYLYQFWNZEBB-UHFFFAOYSA-N 0.000 description 1
• TUFPTLPAEQNWJN-UHFFFAOYSA-N 6-amino-n-methylnaphthalene-1-carboxamide Chemical compound NC1=CC=C2C(C(=O)NC)=CC=CC2=C1 TUFPTLPAEQNWJN-UHFFFAOYSA-N 0.000 description 1
• CKSZZOAKPXZMAT-UHFFFAOYSA-N 6-aminonaphthalene-1-carboxylic acid Chemical compound OC(=O)C1=CC=CC2=CC(N)=CC=C21 CKSZZOAKPXZMAT-UHFFFAOYSA-N 0.000 description 1
• BIIXVAHSLRLVJB-UHFFFAOYSA-N 6-bromonaphthalene-2-carbonitrile Chemical compound C1=C(C#N)C=CC2=CC(Br)=CC=C21 BIIXVAHSLRLVJB-UHFFFAOYSA-N 0.000 description 1
• WVQOLQXCEBJQIM-UHFFFAOYSA-N 6-pyrimidin-2-ylnaphthalen-2-amine Chemical compound C1=CC2=CC(N)=CC=C2C=C1C1=NC=CC=N1 WVQOLQXCEBJQIM-UHFFFAOYSA-N 0.000 description 1
• 239000005541 ACE inhibitor Substances 0.000 description 1
• 208000010444 Acidosis Diseases 0.000 description 1
• 208000009304 Acute Kidney Injury Diseases 0.000 description 1
• 229940077274 Alpha glucosidase inhibitor Drugs 0.000 description 1
• GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
• USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 1
• 239000005695 Ammonium acetate Substances 0.000 description 1
• 101100460776 Arabidopsis thaliana NPY2 gene Proteins 0.000 description 1
• 101100460788 Arabidopsis thaliana NPY5 gene Proteins 0.000 description 1
• 239000004475 Arginine Substances 0.000 description 1
• XUKUURHRXDUEBC-KAYWLYCHSA-N Atorvastatin Chemical compound C=1C=CC=CC=1C1=C(C=2C=CC(F)=CC=2)N(CC[C@@H](O)C[C@@H](O)CC(O)=O)C(C(C)C)=C1C(=O)NC1=CC=CC=C1 XUKUURHRXDUEBC-KAYWLYCHSA-N 0.000 description 1
• XUKUURHRXDUEBC-UHFFFAOYSA-N Atorvastatin Natural products C=1C=CC=CC=1C1=C(C=2C=CC(F)=CC=2)N(CCC(O)CC(O)CC(O)=O)C(C(C)C)=C1C(=O)NC1=CC=CC=C1 XUKUURHRXDUEBC-UHFFFAOYSA-N 0.000 description 1
• PTQXTEKSNBVPQJ-UHFFFAOYSA-N Avasimibe Chemical compound CC(C)C1=CC(C(C)C)=CC(C(C)C)=C1CC(=O)NS(=O)(=O)OC1=C(C(C)C)C=CC=C1C(C)C PTQXTEKSNBVPQJ-UHFFFAOYSA-N 0.000 description 1
• LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
• 239000004072 C09CA03 - Valsartan Substances 0.000 description 1
• 239000002947 C09CA04 - Irbesartan Substances 0.000 description 1
• 239000002081 C09CA05 - Tasosartan Substances 0.000 description 1
• 239000005537 C09CA07 - Telmisartan Substances 0.000 description 1
• NVNIJDRNMBATRE-UHFFFAOYSA-N CC(C)(C)C(OCOP(CN(c(cc1)cc2c1c(C(NC)=O)ccc2)S(c1cc(Cl)cc(Cl)c1)=O)(O)=O)=O Chemical compound CC(C)(C)C(OCOP(CN(c(cc1)cc2c1c(C(NC)=O)ccc2)S(c1cc(Cl)cc(Cl)c1)=O)(O)=O)=O NVNIJDRNMBATRE-UHFFFAOYSA-N 0.000 description 1
• UEAOZKSSMCDHAM-UHFFFAOYSA-O CCOP(C(N(c1c(cccc2NC(Nc3ccccc3)=O)c2ccc1)S(c1cc(Cl)cc(Cl)c1)(=O)=O)[OH+]CC)O Chemical compound CCOP(C(N(c1c(cccc2NC(Nc3ccccc3)=O)c2ccc1)S(c1cc(Cl)cc(Cl)c1)(=O)=O)[OH+]CC)O UEAOZKSSMCDHAM-UHFFFAOYSA-O 0.000 description 1
• GHOSNRCGJFBJIB-UHFFFAOYSA-N Candesartan cilexetil Chemical compound C=12N(CC=3C=CC(=CC=3)C=3C(=CC=CC=3)C3=NNN=N3)C(OCC)=NC2=CC=CC=1C(=O)OC(C)OC(=O)OC1CCCCC1 GHOSNRCGJFBJIB-UHFFFAOYSA-N 0.000 description 1
• 239000004215 Carbon black (E152) Substances 0.000 description 1
• BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
• 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
• ZRLIFEQCMCLKDP-UHFFFAOYSA-O Cc1cc(C)cc([SH+](N(CP(O)(O)=O)c2cccc3c2cccc3C(NC)=O)=O)c1 Chemical compound Cc1cc(C)cc([SH+](N(CP(O)(O)=O)c2cccc3c2cccc3C(NC)=O)=O)c1 ZRLIFEQCMCLKDP-UHFFFAOYSA-O 0.000 description 1
• NLFHTRHYPVSVGF-UHFFFAOYSA-O Cc1cc(c(N(CP(O)(O)=O)[S+](c2cc(Cl)cc(Cl)c2)(O)=O)ccc2)c2nn1 Chemical compound Cc1cc(c(N(CP(O)(O)=O)[S+](c2cc(Cl)cc(Cl)c2)(O)=O)ccc2)c2nn1 NLFHTRHYPVSVGF-UHFFFAOYSA-O 0.000 description 1
• JZUFKLXOESDKRF-UHFFFAOYSA-N Chlorothiazide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC2=C1NCNS2(=O)=O JZUFKLXOESDKRF-UHFFFAOYSA-N 0.000 description 1
• 229920001268 Cholestyramine Polymers 0.000 description 1
• 229910021595 Copper(I) iodide Inorganic materials 0.000 description 1
• AAWZDTNXLSGCEK-UHFFFAOYSA-N Cordycepinsaeure Natural products OC1CC(O)(C(O)=O)CC(O)C1O AAWZDTNXLSGCEK-UHFFFAOYSA-N 0.000 description 1
• 102000004328 Cytochrome P-450 CYP3A Human genes 0.000 description 1
• 108010081668 Cytochrome P-450 CYP3A Proteins 0.000 description 1
• FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
• 101000783577 Dendroaspis angusticeps Thrombostatin Proteins 0.000 description 1
• 101000783578 Dendroaspis jamesoni kaimosae Dendroaspin Proteins 0.000 description 1
• YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical compound [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 description 1
• 208000008960 Diabetic foot Diseases 0.000 description 1
• 102100025012 Dipeptidyl peptidase 4 Human genes 0.000 description 1
• 208000032928 Dyslipidaemia Diseases 0.000 description 1
• 241000588724 Escherichia coli Species 0.000 description 1
• 108010011459 Exenatide Proteins 0.000 description 1
• 102000027487 Fructose-Bisphosphatase Human genes 0.000 description 1
• 108010017464 Fructose-Bisphosphatase Proteins 0.000 description 1
• 229940098788 GABA receptor antagonist Drugs 0.000 description 1
• 101710198884 GATA-type zinc finger protein 1 Proteins 0.000 description 1
• 108091007911 GSKs Proteins 0.000 description 1
• 229940122904 Glucagon receptor antagonist Drugs 0.000 description 1
• FAEKWTJYAYMJKF-QHCPKHFHSA-N GlucoNorm Chemical compound C1=C(C(O)=O)C(OCC)=CC(CC(=O)N[C@@H](CC(C)C)C=2C(=CC=CC=2)N2CCCCC2)=C1 FAEKWTJYAYMJKF-QHCPKHFHSA-N 0.000 description 1
• 102000003638 Glucose-6-Phosphatase Human genes 0.000 description 1
• 108010086800 Glucose-6-Phosphatase Proteins 0.000 description 1
• WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
• 108010001483 Glycogen Synthase Proteins 0.000 description 1
• 102000004103 Glycogen Synthase Kinases Human genes 0.000 description 1
• 201000005569 Gout Diseases 0.000 description 1
• 102100030488 HEAT repeat-containing protein 6 Human genes 0.000 description 1
• 229940121710 HMGCoA reductase inhibitor Drugs 0.000 description 1
• 101000990566 Homo sapiens HEAT repeat-containing protein 6 Proteins 0.000 description 1
• 101000801684 Homo sapiens Phospholipid-transporting ATPase ABCA1 Proteins 0.000 description 1
• 101000684208 Homo sapiens Prolyl endopeptidase FAP Proteins 0.000 description 1
• 101001067951 Homo sapiens Protein phosphatase 1 regulatory subunit 3B Proteins 0.000 description 1
• 101150013372 Htr2c gene Proteins 0.000 description 1
• 206010060378 Hyperinsulinaemia Diseases 0.000 description 1
• 206010010164 Hypertension complications Diseases 0.000 description 1
• 201000001431 Hyperuricemia Diseases 0.000 description 1
• 208000013016 Hypoglycemia Diseases 0.000 description 1
• DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
• 102000004877 Insulin Human genes 0.000 description 1
• 108090001061 Insulin Proteins 0.000 description 1
• 206010022489 Insulin Resistance Diseases 0.000 description 1
• 102000036770 Islet Amyloid Polypeptide Human genes 0.000 description 1
• 108010041872 Islet Amyloid Polypeptide Proteins 0.000 description 1
• 208000007976 Ketosis Diseases 0.000 description 1
• 239000005909 Kieselgur Substances 0.000 description 1
• ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
• CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
• WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
• 208000001145 Metabolic Syndrome Diseases 0.000 description 1
• 206010027417 Metabolic acidosis Diseases 0.000 description 1
• AFVFQIVMOAPDHO-UHFFFAOYSA-M Methanesulfonate Chemical compound CS([O-])(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-M 0.000 description 1
• 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
• IBAQFPQHRJAVAV-ULAWRXDQSA-N Miglitol Chemical compound OCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO IBAQFPQHRJAVAV-ULAWRXDQSA-N 0.000 description 1
• FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
• AHVYPIQETPWLSZ-UHFFFAOYSA-N N-methyl-pyrrolidine Natural products CN1CC=CC1 AHVYPIQETPWLSZ-UHFFFAOYSA-N 0.000 description 1
• 101150111774 NPY5R gene Proteins 0.000 description 1
• UMYWXTCILVOGKY-UHFFFAOYSA-N Nc(c1ccccc1cc1)c1C#Cc1ccccc1 Chemical compound Nc(c1ccccc1cc1)c1C#Cc1ccccc1 UMYWXTCILVOGKY-UHFFFAOYSA-N 0.000 description 1
• 108090000028 Neprilysin Proteins 0.000 description 1
• 102000003729 Neprilysin Human genes 0.000 description 1
• RJMUPKPZZAOQDB-UHFFFAOYSA-N O=[S+](c1cc(Cl)cc(Cl)c1)=O Chemical compound O=[S+](c1cc(Cl)cc(Cl)c1)=O RJMUPKPZZAOQDB-UHFFFAOYSA-N 0.000 description 1
• CVAYSIMXRHBOPK-UHFFFAOYSA-N OP(CN(c(c(cccc1)c1cc1)c1-c1nc2ccccc2[s]1)[S+2](c1cc(Cl)cc(Cl)c1)=O)(O)=O Chemical compound OP(CN(c(c(cccc1)c1cc1)c1-c1nc2ccccc2[s]1)[S+2](c1cc(Cl)cc(Cl)c1)=O)(O)=O CVAYSIMXRHBOPK-UHFFFAOYSA-N 0.000 description 1
• SFQDUFIQXJRHOJ-UHFFFAOYSA-N OP(CN(c(cc1)cc(cc2)c1cc2NC(Nc1ccccc1)=O)S(c1cc(Cl)cc(Cl)c1)(=O)=O)(O)=O Chemical compound OP(CN(c(cc1)cc(cc2)c1cc2NC(Nc1ccccc1)=O)S(c1cc(Cl)cc(Cl)c1)(=O)=O)(O)=O SFQDUFIQXJRHOJ-UHFFFAOYSA-N 0.000 description 1
• DEDUPBVWKKXEIX-UHFFFAOYSA-N OP(CN(c1c(cccc2)c2ccc1C#Cc1ccccc1)S(c1cc(Cl)cc(Cl)c1)(=O)=O)(O)=O Chemical compound OP(CN(c1c(cccc2)c2ccc1C#Cc1ccccc1)S(c1cc(Cl)cc(Cl)c1)(=O)=O)(O)=O DEDUPBVWKKXEIX-UHFFFAOYSA-N 0.000 description 1
• KDEKPZVFRZCVEH-UHFFFAOYSA-N OP(CN(c1c(cccc2NC(Nc3ccccc3)=O)c2ccc1)S(c1cc(Cl)cc(Cl)c1)(=O)=O)(O)=O Chemical compound OP(CN(c1c(cccc2NC(Nc3ccccc3)=O)c2ccc1)S(c1cc(Cl)cc(Cl)c1)(=O)=O)(O)=O KDEKPZVFRZCVEH-UHFFFAOYSA-N 0.000 description 1
• JCXXHXFUIZVQMW-UHFFFAOYSA-P O[N+](c1cc(Cl)cc([S+](N(CP(O)(O)=O)c2cccc3c2cccc3)(O)=O)c1)=O Chemical compound O[N+](c1cc(Cl)cc([S+](N(CP(O)(O)=O)c2cccc3c2cccc3)(O)=O)c1)=O JCXXHXFUIZVQMW-UHFFFAOYSA-P 0.000 description 1
• VDNUKOVWGXDYRP-UHFFFAOYSA-O O[S+](c1cc(Cl)cc(Cl)c1)(Nc1cccc2c1nccn2)=O Chemical compound O[S+](c1cc(Cl)cc(Cl)c1)(Nc1cccc2c1nccn2)=O VDNUKOVWGXDYRP-UHFFFAOYSA-O 0.000 description 1
• VPHVUTLQADYSRU-UHFFFAOYSA-O O[S+](c1cc(Cl)cc(Cl)c1)(Nc1cccc2c1ncnc2)=O Chemical compound O[S+](c1cc(Cl)cc(Cl)c1)(Nc1cccc2c1ncnc2)=O VPHVUTLQADYSRU-UHFFFAOYSA-O 0.000 description 1
• 206010030113 Oedema Diseases 0.000 description 1
• 239000005480 Olmesartan Substances 0.000 description 1
• ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical compound C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 description 1
• 108010016731 PPAR gamma Proteins 0.000 description 1
• 229930040373 Paraformaldehyde Natural products 0.000 description 1
• 101150003085 Pdcl gene Proteins 0.000 description 1
• CYTYCFOTNPOANT-UHFFFAOYSA-N Perchloroethylene Chemical compound ClC(Cl)=C(Cl)Cl CYTYCFOTNPOANT-UHFFFAOYSA-N 0.000 description 1
• 102100038824 Peroxisome proliferator-activated receptor delta Human genes 0.000 description 1
• 102100038825 Peroxisome proliferator-activated receptor gamma Human genes 0.000 description 1
• 102000014750 Phosphorylase Kinase Human genes 0.000 description 1
• 108010064071 Phosphorylase Kinase Proteins 0.000 description 1
• ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
• 102100040918 Pro-glucagon Human genes 0.000 description 1
• 229940123924 Protein kinase C inhibitor Drugs 0.000 description 1
• 102100034504 Protein phosphatase 1 regulatory subunit 3B Human genes 0.000 description 1
• WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical compound C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 description 1
• LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 1
• AAWZDTNXLSGCEK-ZHQZDSKASA-N Quinic acid Natural products O[C@H]1CC(O)(C(O)=O)C[C@H](O)C1O AAWZDTNXLSGCEK-ZHQZDSKASA-N 0.000 description 1
• IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 1
• 239000007868 Raney catalyst Substances 0.000 description 1
• NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 1
• 229910000564 Raney nickel Inorganic materials 0.000 description 1
• 208000033626 Renal failure acute Diseases 0.000 description 1
• 208000017442 Retinal disease Diseases 0.000 description 1
• 206010038923 Retinopathy Diseases 0.000 description 1
• 108700031620 S-acetylthiorphan Proteins 0.000 description 1
• RYMZZMVNJRMUDD-UHFFFAOYSA-N SJ000286063 Natural products C12C(OC(=O)C(C)(C)CC)CC(C)C=C2C=CC(C)C1CCC1CC(O)CC(=O)O1 RYMZZMVNJRMUDD-UHFFFAOYSA-N 0.000 description 1
• 229940123518 Sodium/glucose cotransporter 2 inhibitor Drugs 0.000 description 1
• KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
• 229940100389 Sulfonylurea Drugs 0.000 description 1
• FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 1
• 229940123464 Thiazolidinedione Drugs 0.000 description 1
• JLRGJRBPOGGCBT-UHFFFAOYSA-N Tolbutamide Chemical compound CCCCNC(=O)NS(=O)(=O)C1=CC=C(C)C=C1 JLRGJRBPOGGCBT-UHFFFAOYSA-N 0.000 description 1
• KJADKKWYZYXHBB-XBWDGYHZSA-N Topiramic acid Chemical compound C1O[C@@]2(COS(N)(=O)=O)OC(C)(C)O[C@H]2[C@@H]2OC(C)(C)O[C@@H]21 KJADKKWYZYXHBB-XBWDGYHZSA-N 0.000 description 1
• XSTXAVWGXDQKEL-UHFFFAOYSA-N Trichloroethylene Chemical compound ClC=C(Cl)Cl XSTXAVWGXDQKEL-UHFFFAOYSA-N 0.000 description 1
• 239000007983 Tris buffer Substances 0.000 description 1
• 102000008316 Type 4 Melanocortin Receptor Human genes 0.000 description 1
• 108010021436 Type 4 Melanocortin Receptor Proteins 0.000 description 1
• 101710204865 Tyrosine-protein phosphatase 1 Proteins 0.000 description 1
• 208000025865 Ulcer Diseases 0.000 description 1
• LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
• TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
• 229940116731 Uricosuric agent Drugs 0.000 description 1
• FZNCGRZWXLXZSZ-CIQUZCHMSA-N Voglibose Chemical compound OCC(CO)N[C@H]1C[C@](O)(CO)[C@@H](O)[C@H](O)[C@H]1O FZNCGRZWXLXZSZ-CIQUZCHMSA-N 0.000 description 1
• HTXCIGFDLZDEON-UHFFFAOYSA-N [(2-benzoylnaphthalen-1-yl)-(3,5-dichlorophenyl)sulfonylamino]methylphosphonic acid Chemical compound C=1C(Cl)=CC(Cl)=CC=1S(=O)(=O)N(CP(O)(=O)O)C(C1=CC=CC=C1C=C1)=C1C(=O)C1=CC=CC=C1 HTXCIGFDLZDEON-UHFFFAOYSA-N 0.000 description 1
• QOQVCDAUKFBTLS-UHFFFAOYSA-N [(2-carbamoylnaphthalen-1-yl)-(3,5-dichlorophenyl)sulfonylamino]methylphosphonic acid Chemical compound NC(=O)C1=CC=C2C=CC=CC2=C1N(CP(O)(O)=O)S(=O)(=O)C1=CC(Cl)=CC(Cl)=C1 QOQVCDAUKFBTLS-UHFFFAOYSA-N 0.000 description 1
• NJHCJNSCQDJSBD-UHFFFAOYSA-N [(3,5-dichloro-4-fluorophenyl)sulfonyl-naphthalen-1-ylamino]methylphosphonic acid Chemical compound C=1C=CC2=CC=CC=C2C=1N(CP(O)(=O)O)S(=O)(=O)C1=CC(Cl)=C(F)C(Cl)=C1 NJHCJNSCQDJSBD-UHFFFAOYSA-N 0.000 description 1
• BGTCJJWRBBPSAN-UHFFFAOYSA-N [(3,5-dichlorophenyl)sulfonyl-(2-ethynylnaphthalen-1-yl)amino]methylphosphonic acid Chemical compound C#CC=1C=CC2=CC=CC=C2C=1N(CP(O)(=O)O)S(=O)(=O)C1=CC(Cl)=CC(Cl)=C1 BGTCJJWRBBPSAN-UHFFFAOYSA-N 0.000 description 1
• OEYNRKJQHVRALP-UHFFFAOYSA-N [(3,5-dichlorophenyl)sulfonyl-(2-methylnaphthalen-1-yl)amino]methylphosphonic acid Chemical compound CC1=CC=C2C=CC=CC2=C1N(CP(O)(O)=O)S(=O)(=O)C1=CC(Cl)=CC(Cl)=C1 OEYNRKJQHVRALP-UHFFFAOYSA-N 0.000 description 1
• PZRHLGNOVJGLDQ-UHFFFAOYSA-N [(3,5-dichlorophenyl)sulfonyl-(3-methylisoquinolin-5-yl)amino]methylphosphonic acid Chemical compound C1=CC=C2C=NC(C)=CC2=C1N(CP(O)(O)=O)S(=O)(=O)C1=CC(Cl)=CC(Cl)=C1 PZRHLGNOVJGLDQ-UHFFFAOYSA-N 0.000 description 1
• HDTWLTBEILKBFF-UHFFFAOYSA-N [(3,5-dichlorophenyl)sulfonyl-[2-(dimethylcarbamoyl)naphthalen-1-yl]amino]methylphosphonic acid Chemical compound CN(C)C(=O)C1=CC=C2C=CC=CC2=C1N(CP(O)(O)=O)S(=O)(=O)C1=CC(Cl)=CC(Cl)=C1 HDTWLTBEILKBFF-UHFFFAOYSA-N 0.000 description 1
• IYHKFNLGIDMWFB-UHFFFAOYSA-N [(3,5-dichlorophenyl)sulfonyl-[2-(pyrrolidine-1-carbonyl)naphthalen-1-yl]amino]methylphosphonic acid Chemical compound C=1C(Cl)=CC(Cl)=CC=1S(=O)(=O)N(CP(O)(=O)O)C(C1=CC=CC=C1C=C1)=C1C(=O)N1CCCC1 IYHKFNLGIDMWFB-UHFFFAOYSA-N 0.000 description 1
• VHGIUWJISRNWMO-UHFFFAOYSA-N [(3,5-dimethylphenyl)sulfonyl-[5-(methylcarbamoyl)naphthalen-2-yl]amino]methylphosphonic acid Chemical compound C=1C=C2C(C(=O)NC)=CC=CC2=CC=1N(CP(O)(O)=O)S(=O)(=O)C1=CC(C)=CC(C)=C1 VHGIUWJISRNWMO-UHFFFAOYSA-N 0.000 description 1
• NATIBSDWVFLYIW-UHFFFAOYSA-N [(3,5-dimethylphenyl)sulfonyl-naphthalen-1-ylamino]methylphosphonic acid Chemical compound CC1=CC(C)=CC(S(=O)(=O)N(CP(O)(O)=O)C=2C3=CC=CC=C3C=CC=2)=C1 NATIBSDWVFLYIW-UHFFFAOYSA-N 0.000 description 1
• WLEFUJADNZSOIW-UHFFFAOYSA-N [(3-amino-5-chlorophenyl)sulfonyl-naphthalen-1-ylamino]methylphosphonic acid Chemical compound NC1=CC(Cl)=CC(S(=O)(=O)N(CP(O)(O)=O)C=2C3=CC=CC=C3C=CC=2)=C1 WLEFUJADNZSOIW-UHFFFAOYSA-N 0.000 description 1
• SXLGPQHXKDKIFZ-UHFFFAOYSA-N [(3-chloro-5-cyanophenyl)sulfonyl-naphthalen-1-ylamino]methylphosphonic acid Chemical compound C=1C=CC2=CC=CC=C2C=1N(CP(O)(=O)O)S(=O)(=O)C1=CC(Cl)=CC(C#N)=C1 SXLGPQHXKDKIFZ-UHFFFAOYSA-N 0.000 description 1
• IFZBHENNHKQELW-UHFFFAOYSA-N [(3-chloro-5-fluorophenyl)sulfonyl-naphthalen-1-ylamino]methylphosphonic acid Chemical compound C=1C=CC2=CC=CC=C2C=1N(CP(O)(=O)O)S(=O)(=O)C1=CC(F)=CC(Cl)=C1 IFZBHENNHKQELW-UHFFFAOYSA-N 0.000 description 1
• MVOSJRFRYOHEAJ-UHFFFAOYSA-N [(3-chloro-5-nitrophenyl)sulfonyl-naphthalen-1-ylamino]methylphosphonic acid Chemical compound C=1C=CC2=CC=CC=C2C=1N(CP(O)(=O)O)S(=O)(=O)C1=CC(Cl)=CC([N+]([O-])=O)=C1 MVOSJRFRYOHEAJ-UHFFFAOYSA-N 0.000 description 1
• FDKIDFYIEWFERB-UHFFFAOYSA-N [2-butyl-5-chloro-3-[[4-[2-(2h-tetrazol-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol;potassium Chemical compound [K].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C=2NN=NN=2)C=C1 FDKIDFYIEWFERB-UHFFFAOYSA-N 0.000 description 1
• UMPZEEZAOPSURO-UHFFFAOYSA-N [6-[(2-methylpropan-2-yl)oxycarbonylamino]naphthalen-2-yl]boronic acid Chemical compound C1=C(B(O)O)C=CC2=CC(NC(=O)OC(C)(C)C)=CC=C21 UMPZEEZAOPSURO-UHFFFAOYSA-N 0.000 description 1
• LVIROKADBUJREO-UHFFFAOYSA-N [[(3,5-dichlorophenyl)sulfonyl-[5-(methylcarbamoyl)naphthalen-2-yl]amino]methyl-(2,2-dimethylpropanoyloxymethylperoxy)phosphoryl]peroxymethyl 2,2-dimethylpropanoate Chemical compound C=1C=C2C(C(=O)NC)=CC=CC2=CC=1N(CP(=O)(OOCOC(=O)C(C)(C)C)OOCOC(=O)C(C)(C)C)S(=O)(=O)C1=CC(Cl)=CC(Cl)=C1 LVIROKADBUJREO-UHFFFAOYSA-N 0.000 description 1
• OWZMZASEMPACHD-UHFFFAOYSA-N [[2-(1,3-benzothiazol-2-yl)naphthalen-1-yl]-(3,5-dichlorophenyl)sulfonylamino]methylphosphonic acid Chemical compound N=1C2=CC=CC=C2SC=1C=1C=CC2=CC=CC=C2C=1N(CP(O)(=O)O)S(=O)(=O)C1=CC(Cl)=CC(Cl)=C1 OWZMZASEMPACHD-UHFFFAOYSA-N 0.000 description 1
• AEYKPWITUADCGA-UHFFFAOYSA-N [[2-(1,3-benzoxazol-2-yl)naphthalen-1-yl]-(3,5-dichlorophenyl)sulfonylamino]methylphosphonic acid Chemical compound N=1C2=CC=CC=C2OC=1C=1C=CC2=CC=CC=C2C=1N(CP(O)(=O)O)S(=O)(=O)C1=CC(Cl)=CC(Cl)=C1 AEYKPWITUADCGA-UHFFFAOYSA-N 0.000 description 1
• FXWFLLIHJWKIAF-UHFFFAOYSA-N [[3-chloro-5-(trifluoromethyl)phenyl]sulfonyl-naphthalen-1-ylamino]methylphosphonic acid Chemical compound C=1C=CC2=CC=CC=C2C=1N(CP(O)(=O)O)S(=O)(=O)C1=CC(Cl)=CC(C(F)(F)F)=C1 FXWFLLIHJWKIAF-UHFFFAOYSA-N 0.000 description 1
• 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 description 1
• 238000010521 absorption reaction Methods 0.000 description 1
• 229960002632 acarbose Drugs 0.000 description 1
• XUFXOAAUWZOOIT-UHFFFAOYSA-N acarviostatin I01 Natural products OC1C(O)C(NC2C(C(O)C(O)C(CO)=C2)O)C(C)OC1OC(C(C1O)O)C(CO)OC1OC1C(CO)OC(O)C(O)C1O XUFXOAAUWZOOIT-UHFFFAOYSA-N 0.000 description 1
• 150000001242 acetic acid derivatives Chemical class 0.000 description 1
• 230000009471 action Effects 0.000 description 1
• 201000011040 acute kidney failure Diseases 0.000 description 1
• 208000012998 acute renal failure Diseases 0.000 description 1
• 125000002252 acyl group Chemical group 0.000 description 1
• 125000005041 acyloxyalkyl group Chemical group 0.000 description 1
• 125000005073 adamantyl group Chemical group C12(CC3CC(CC(C1)C3)C2)* 0.000 description 1
• 239000000670 adrenergic alpha-2 receptor antagonist Substances 0.000 description 1
• 239000000674 adrenergic antagonist Substances 0.000 description 1
• 238000012382 advanced drug delivery Methods 0.000 description 1
• 229940127252 advanced glycation end product inhibitor Drugs 0.000 description 1
• 239000005456 alcohol based solvent Substances 0.000 description 1
• 239000003288 aldose reductase inhibitor Substances 0.000 description 1
• 229940090865 aldose reductase inhibitors used in diabetes Drugs 0.000 description 1
• 125000001931 aliphatic group Chemical group 0.000 description 1
• 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
• 125000003342 alkenyl group Chemical group 0.000 description 1
• 125000000304 alkynyl group Chemical group 0.000 description 1
• 239000003888 alpha glucosidase inhibitor Substances 0.000 description 1
• BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
• 150000001412 amines Chemical class 0.000 description 1
• 235000019257 ammonium acetate Nutrition 0.000 description 1
• 229940043376 ammonium acetate Drugs 0.000 description 1
• 239000000908 ammonium hydroxide Substances 0.000 description 1
• 229940126317 angiotensin II receptor antagonist Drugs 0.000 description 1
• 229940044094 angiotensin-converting-enzyme inhibitor Drugs 0.000 description 1
• 150000008064 anhydrides Chemical class 0.000 description 1
• 125000002178 anthracenyl group Chemical group C1(=CC=CC2=CC3=CC=CC=C3C=C12)* 0.000 description 1
• 230000003178 anti-diabetic effect Effects 0.000 description 1
• 230000000840 anti-viral effect Effects 0.000 description 1
• 239000002220 antihypertensive agent Substances 0.000 description 1
• 229940030600 antihypertensive agent Drugs 0.000 description 1
• 239000003524 antilipemic agent Substances 0.000 description 1
• 229940127218 antiplatelet drug Drugs 0.000 description 1
• 230000006907 apoptotic process Effects 0.000 description 1
• 239000000010 aprotic solvent Substances 0.000 description 1
• 239000003125 aqueous solvent Substances 0.000 description 1
• ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
• 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
• 235000003704 aspartic acid Nutrition 0.000 description 1
• 125000004429 atom Chemical group 0.000 description 1
• 229960005370 atorvastatin Drugs 0.000 description 1
• 229950010046 avasimibe Drugs 0.000 description 1
• 108010014210 axokine Proteins 0.000 description 1
• 210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 description 1
• 239000011324 bead Substances 0.000 description 1
• 235000013871 bee wax Nutrition 0.000 description 1
• 239000012166 beeswax Substances 0.000 description 1
• RFRXIWQYSOIBDI-UHFFFAOYSA-N benzarone Chemical compound CCC=1OC2=CC=CC=C2C=1C(=O)C1=CC=C(O)C=C1 RFRXIWQYSOIBDI-UHFFFAOYSA-N 0.000 description 1
• BEHWRDLJAHRTGD-UHFFFAOYSA-N benzylazanium;1-(benzylcarbamoylamino)naphthalene-2-carboxylate Chemical compound [NH3+]CC1=CC=CC=C1.[O-]C(=O)C1=CC=C2C=CC=CC2=C1NC(=O)NCC1=CC=CC=C1 BEHWRDLJAHRTGD-UHFFFAOYSA-N 0.000 description 1
• 239000002876 beta blocker Substances 0.000 description 1
• 229940097320 beta blocking agent Drugs 0.000 description 1
• OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
• 229960000516 bezafibrate Drugs 0.000 description 1
• IIBYAHWJQTYFKB-UHFFFAOYSA-N bezafibrate Chemical compound C1=CC(OC(C)(C)C(O)=O)=CC=C1CCNC(=O)C1=CC=C(Cl)C=C1 IIBYAHWJQTYFKB-UHFFFAOYSA-N 0.000 description 1
• YNHIGQDRGKUECZ-UHFFFAOYSA-L bis(triphenylphosphine)palladium(ii) dichloride Chemical compound [Cl-].[Cl-].[Pd+2].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 YNHIGQDRGKUECZ-UHFFFAOYSA-L 0.000 description 1
• KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
• 229910052796 boron Inorganic materials 0.000 description 1
• 125000005620 boronic acid group Chemical group 0.000 description 1
• 239000000872 buffer Substances 0.000 description 1
• KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
• 125000004744 butyloxycarbonyl group Chemical group 0.000 description 1
• FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 1
• 229910000024 caesium carbonate Inorganic materials 0.000 description 1
• 229960004349 candesartan cilexetil Drugs 0.000 description 1
• 229930003827 cannabinoid Natural products 0.000 description 1
• 239000003557 cannabinoid Substances 0.000 description 1
• QGJOPFRUJISHPQ-NJFSPNSNSA-N carbon disulfide-14c Chemical compound S=[14C]=S QGJOPFRUJISHPQ-NJFSPNSNSA-N 0.000 description 1
• 229950005499 carbon tetrachloride Drugs 0.000 description 1
• 239000001768 carboxy methyl cellulose Substances 0.000 description 1
• 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
• 150000001732 carboxylic acid derivatives Chemical group 0.000 description 1
• 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
• 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
• 229940105329 carboxymethylcellulose Drugs 0.000 description 1
• 230000003197 catalytic effect Effects 0.000 description 1
• 238000005119 centrifugation Methods 0.000 description 1
• 239000003610 charcoal Substances 0.000 description 1
• JUFFVKRROAPVBI-PVOYSMBESA-N chembl1210015 Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N[C@H]1[C@@H]([C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO[C@]3(O[C@@H](C[C@H](O)[C@H](O)CO)[C@H](NC(C)=O)[C@@H](O)C3)C(O)=O)O2)O)[C@@H](CO)O1)NC(C)=O)C(=O)NCC(=O)NCC(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CO)C(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 JUFFVKRROAPVBI-PVOYSMBESA-N 0.000 description 1
• 239000003795 chemical substances by application Substances 0.000 description 1
• 239000012320 chlorinating reagent Substances 0.000 description 1
• 125000001309 chloro group Chemical group Cl* 0.000 description 1
• GGRHYQCXXYLUTL-UHFFFAOYSA-N chloromethyl 2,2-dimethylpropanoate Chemical compound CC(C)(C)C(=O)OCCl GGRHYQCXXYLUTL-UHFFFAOYSA-N 0.000 description 1
• 239000003354 cholesterol ester transfer protein inhibitor Substances 0.000 description 1
• 239000008119 colloidal silica Substances 0.000 description 1
• MPTQRFCYZCXJFQ-UHFFFAOYSA-L copper(II) chloride dihydrate Chemical compound O.O.[Cl-].[Cl-].[Cu+2] MPTQRFCYZCXJFQ-UHFFFAOYSA-L 0.000 description 1
• LSXDOTMGLUJQCM-UHFFFAOYSA-M copper(i) iodide Chemical compound I[Cu] LSXDOTMGLUJQCM-UHFFFAOYSA-M 0.000 description 1
• 239000013078 crystal Substances 0.000 description 1
• 125000006165 cyclic alkyl group Chemical group 0.000 description 1
• 125000004122 cyclic group Chemical group 0.000 description 1
• 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
• 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
• HPXRVTGHNJAIIH-UHFFFAOYSA-N cyclohexanol Chemical compound OC1CCCCC1 HPXRVTGHNJAIIH-UHFFFAOYSA-N 0.000 description 1
• 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
• 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
• 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
• 230000007850 degeneration Effects 0.000 description 1
• 230000002074 deregulated effect Effects 0.000 description 1
• 229910052805 deuterium Inorganic materials 0.000 description 1
• 229960004597 dexfenfluramine Drugs 0.000 description 1
• LWJYMKDMGMOTSB-UHFFFAOYSA-L dichlorotin;hydrate Chemical class O.Cl[Sn]Cl LWJYMKDMGMOTSB-UHFFFAOYSA-L 0.000 description 1
• 150000005690 diesters Chemical class 0.000 description 1
• ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
• BNKDGTGYTVFGBY-UHFFFAOYSA-N diethoxyphosphorylmethyl trifluoromethanesulfonate Chemical compound CCOP(=O)(OCC)COS(=O)(=O)C(F)(F)F BNKDGTGYTVFGBY-UHFFFAOYSA-N 0.000 description 1
• HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
• 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 description 1
• 208000035475 disorder Diseases 0.000 description 1
• 238000004090 dissolution Methods 0.000 description 1
• 238000006345 epimerization reaction Methods 0.000 description 1
• 229960000573 eprosartan mesylate Drugs 0.000 description 1
• DJSLTDBPKHORNY-XMMWENQYSA-N eprosartan methanesulfonate Chemical compound CS(O)(=O)=O.C=1C=C(C(O)=O)C=CC=1CN1C(CCCC)=NC=C1\C=C(C(O)=O)/CC1=CC=CS1 DJSLTDBPKHORNY-XMMWENQYSA-N 0.000 description 1
• UFZOPKFMKMAWLU-UHFFFAOYSA-N ethoxy(methyl)phosphinic acid Chemical class CCOP(C)(O)=O UFZOPKFMKMAWLU-UHFFFAOYSA-N 0.000 description 1
• 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 1
• DQYBDCGIPTYXML-UHFFFAOYSA-N ethoxyethane;hydrate Chemical compound O.CCOCC DQYBDCGIPTYXML-UHFFFAOYSA-N 0.000 description 1
• JCXLZWMDXJFOOI-WCCKRBBISA-N ethyl (2s)-2-aminopropanoate;hydrochloride Chemical compound Cl.CCOC(=O)[C@H](C)N JCXLZWMDXJFOOI-WCCKRBBISA-N 0.000 description 1
• DNJIEGIFACGWOD-UHFFFAOYSA-N ethyl mercaptane Natural products CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 1
• DEFVIWRASFVYLL-UHFFFAOYSA-N ethylene glycol bis(2-aminoethyl)tetraacetic acid Chemical compound OC(=O)CN(CC(O)=O)CCOCCOCCN(CC(O)=O)CC(O)=O DEFVIWRASFVYLL-UHFFFAOYSA-N 0.000 description 1
• GATNOFPXSDHULC-UHFFFAOYSA-N ethylphosphonic acid Chemical compound CCP(O)(O)=O GATNOFPXSDHULC-UHFFFAOYSA-N 0.000 description 1
• 238000001704 evaporation Methods 0.000 description 1
• 230000008020 evaporation Effects 0.000 description 1
• 229960001519 exenatide Drugs 0.000 description 1
• OLNTVTPDXPETLC-XPWALMASSA-N ezetimibe Chemical compound N1([C@@H]([C@H](C1=O)CC[C@H](O)C=1C=CC(F)=CC=1)C=1C=CC(O)=CC=1)C1=CC=C(F)C=C1 OLNTVTPDXPETLC-XPWALMASSA-N 0.000 description 1
• 229960000815 ezetimibe Drugs 0.000 description 1
• 239000003925 fat Substances 0.000 description 1
• 229960002297 fenofibrate Drugs 0.000 description 1
• YMTINGFKWWXKFG-UHFFFAOYSA-N fenofibrate Chemical compound C1=CC(OC(C)(C)C(=O)OC(C)C)=CC=C1C(=O)C1=CC=C(Cl)C=C1 YMTINGFKWWXKFG-UHFFFAOYSA-N 0.000 description 1
• 229940125753 fibrate Drugs 0.000 description 1
• 238000011049 filling Methods 0.000 description 1
• 239000007941 film coated tablet Substances 0.000 description 1
• 239000012065 filter cake Substances 0.000 description 1
• 239000000796 flavoring agent Substances 0.000 description 1
• 235000013355 food flavoring agent Nutrition 0.000 description 1
• 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
• 238000001640 fractional crystallisation Methods 0.000 description 1
• 125000000524 functional group Chemical group 0.000 description 1
• 125000002541 furyl group Chemical group 0.000 description 1
• 239000007789 gas Substances 0.000 description 1
• 229940052308 general anesthetics halogenated hydrocarbons Drugs 0.000 description 1
• 229960004580 glibenclamide Drugs 0.000 description 1
• WIGIZIANZCJQQY-RUCARUNLSA-N glimepiride Chemical compound O=C1C(CC)=C(C)CN1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)N[C@@H]2CC[C@@H](C)CC2)C=C1 WIGIZIANZCJQQY-RUCARUNLSA-N 0.000 description 1
• 229960004346 glimepiride Drugs 0.000 description 1
• 235000001727 glucose Nutrition 0.000 description 1
• 230000009229 glucose formation Effects 0.000 description 1
• 230000004153 glucose metabolism Effects 0.000 description 1
• 239000004220 glutamic acid Substances 0.000 description 1
• 235000013922 glutamic acid Nutrition 0.000 description 1
• ZNNLBTZKUZBEKO-UHFFFAOYSA-N glyburide Chemical compound COC1=CC=C(Cl)C=C1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCCCC2)C=C1 ZNNLBTZKUZBEKO-UHFFFAOYSA-N 0.000 description 1
• 229940093915 gynecological organic acid Drugs 0.000 description 1
• 150000008282 halocarbons Chemical class 0.000 description 1
• 125000006341 heptafluoro n-propyl group Chemical group FC(F)(F)C(F)(F)C(F)(F)* 0.000 description 1
• XHJJEWBMBSQVCJ-UHFFFAOYSA-N homocamfin Chemical compound CC(C)C1CC(C)=CC(=O)C1 XHJJEWBMBSQVCJ-UHFFFAOYSA-N 0.000 description 1
• 229950007035 homocamfin Drugs 0.000 description 1
• 229930195733 hydrocarbon Natural products 0.000 description 1
• 229960002003 hydrochlorothiazide Drugs 0.000 description 1
• 238000005984 hydrogenation reaction Methods 0.000 description 1
• 238000007327 hydrogenolysis reaction Methods 0.000 description 1
• 230000007062 hydrolysis Effects 0.000 description 1
• 238000006460 hydrolysis reaction Methods 0.000 description 1
• 150000004679 hydroxides Chemical class 0.000 description 1
• 239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 description 1
• 230000003451 hyperinsulinaemic effect Effects 0.000 description 1
• 201000008980 hyperinsulinism Diseases 0.000 description 1
• 239000005555 hypertensive agent Substances 0.000 description 1
• 230000001771 impaired effect Effects 0.000 description 1
• PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
• RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
• HOBCFUWDNJPFHB-UHFFFAOYSA-N indolizine Chemical compound C1=CC=CN2C=CC=C21 HOBCFUWDNJPFHB-UHFFFAOYSA-N 0.000 description 1
• 150000007529 inorganic bases Chemical class 0.000 description 1
• 229940125396 insulin Drugs 0.000 description 1
• 238000001990 intravenous administration Methods 0.000 description 1
• 229960002198 irbesartan Drugs 0.000 description 1
• YCPOHTHPUREGFM-UHFFFAOYSA-N irbesartan Chemical compound O=C1N(CC=2C=CC(=CC=2)C=2C(=CC=CC=2)C=2[N]N=NN=2)C(CCCC)=NC21CCCC2 YCPOHTHPUREGFM-UHFFFAOYSA-N 0.000 description 1
• 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
• CTAPFRYPJLPFDF-UHFFFAOYSA-N isoxazole Chemical compound C=1C=NOC=1 CTAPFRYPJLPFDF-UHFFFAOYSA-N 0.000 description 1
• 150000002576 ketones Chemical class 0.000 description 1
• 230000004140 ketosis Effects 0.000 description 1
• 208000017169 kidney disease Diseases 0.000 description 1
• 239000004310 lactic acid Substances 0.000 description 1
• 235000014655 lactic acid Nutrition 0.000 description 1
• 230000003902 lesion Effects 0.000 description 1
• 229960004873 levomenthol Drugs 0.000 description 1
• ZEUXAIYYDDCIRX-UHFFFAOYSA-N losartan carboxylic acid Chemical compound CCCCC1=NC(Cl)=C(C(O)=O)N1CC1=CC=C(C=2C(=CC=CC=2)C2=NNN=N2)C=C1 ZEUXAIYYDDCIRX-UHFFFAOYSA-N 0.000 description 1
• 239000000314 lubricant Substances 0.000 description 1
• 239000001630 malic acid Substances 0.000 description 1
• 235000011090 malic acid Nutrition 0.000 description 1
• 229960002510 mandelic acid Drugs 0.000 description 1
• 238000005259 measurement Methods 0.000 description 1
• 239000000155 melt Substances 0.000 description 1
• 238000002844 melting Methods 0.000 description 1
• 230000008018 melting Effects 0.000 description 1
• XZWYZXLIPXDOLR-UHFFFAOYSA-N metformin Chemical compound CN(C)C(=N)NC(N)=N XZWYZXLIPXDOLR-UHFFFAOYSA-N 0.000 description 1
• 229960003105 metformin Drugs 0.000 description 1
• 229940098779 methanesulfonic acid Drugs 0.000 description 1
• GYNNXHKOJHMOHS-UHFFFAOYSA-N methyl-cycloheptane Natural products CC1CCCCCC1 GYNNXHKOJHMOHS-UHFFFAOYSA-N 0.000 description 1
• 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 description 1
• 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 1
• 239000008108 microcrystalline cellulose Substances 0.000 description 1
• 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
• 229940016286 microcrystalline cellulose Drugs 0.000 description 1
• 229960001110 miglitol Drugs 0.000 description 1
• 239000002808 molecular sieve Substances 0.000 description 1
• NKVZIJMCMFLBTK-UHFFFAOYSA-N n-(2-benzoylnaphthalen-1-yl)-3,5-dichloro-n-(3,5-dichlorophenyl)sulfonylbenzenesulfonamide Chemical compound ClC1=CC(Cl)=CC(S(=O)(=O)N(C=2C3=CC=CC=C3C=CC=2C(=O)C=2C=CC=CC=2)S(=O)(=O)C=2C=C(Cl)C=C(Cl)C=2)=C1 NKVZIJMCMFLBTK-UHFFFAOYSA-N 0.000 description 1
• KJQMXWNCDHNZKB-UHFFFAOYSA-N n-(2-benzoylnaphthalen-1-yl)-3,5-dichloro-n-(diethoxyphosphorylmethyl)benzenesulfonamide Chemical compound C=1C(Cl)=CC(Cl)=CC=1S(=O)(=O)N(CP(=O)(OCC)OCC)C(C1=CC=CC=C1C=C1)=C1C(=O)C1=CC=CC=C1 KJQMXWNCDHNZKB-UHFFFAOYSA-N 0.000 description 1
• KQNPSDPZDBPJOC-UHFFFAOYSA-N n-(2-bromonaphthalen-1-yl)-3,5-dichloro-n-(diethoxyphosphorylmethyl)benzenesulfonamide Chemical compound BrC=1C=CC2=CC=CC=C2C=1N(CP(=O)(OCC)OCC)S(=O)(=O)C1=CC(Cl)=CC(Cl)=C1 KQNPSDPZDBPJOC-UHFFFAOYSA-N 0.000 description 1
• VLHJSGYEFBFBAO-UHFFFAOYSA-N n-(2-bromonaphthalen-1-yl)-3,5-dichlorobenzenesulfonamide Chemical compound ClC1=CC(Cl)=CC(S(=O)(=O)NC=2C3=CC=CC=C3C=CC=2Br)=C1 VLHJSGYEFBFBAO-UHFFFAOYSA-N 0.000 description 1
• GXSCPSMITCFJAD-UHFFFAOYSA-N n-(2-phenylethyl)naphthalen-1-amine Chemical compound C=1C=CC2=CC=CC=C2C=1NCCC1=CC=CC=C1 GXSCPSMITCFJAD-UHFFFAOYSA-N 0.000 description 1
• KUZMMOXXAVHTJT-UHFFFAOYSA-N n-(diethoxyphosphorylmethyl)-3,5-dimethyl-n-naphthalen-1-ylbenzenesulfonamide Chemical compound C=1C=CC2=CC=CC=C2C=1N(CP(=O)(OCC)OCC)S(=O)(=O)C1=CC(C)=CC(C)=C1 KUZMMOXXAVHTJT-UHFFFAOYSA-N 0.000 description 1
• RNUYAKZRJRJYRD-UHFFFAOYSA-N n-[(4-cyanophenyl)methyl]-6-[(3,5-dichlorophenyl)sulfonyl-(diethoxyphosphorylmethyl)amino]naphthalene-1-carboxamide Chemical compound C=1C(Cl)=CC(Cl)=CC=1S(=O)(=O)N(CP(=O)(OCC)OCC)C(C=C1C=CC=2)=CC=C1C=2C(=O)NCC1=CC=C(C#N)C=C1 RNUYAKZRJRJYRD-UHFFFAOYSA-N 0.000 description 1
• KJQBSILKDRJTBT-UHFFFAOYSA-N n-[2-(1,3-benzothiazol-2-yl)naphthalen-1-yl]-3,5-dichloro-n-(diethoxyphosphorylmethyl)benzenesulfonamide Chemical compound N=1C2=CC=CC=C2SC=1C=1C=CC2=CC=CC=C2C=1N(CP(=O)(OCC)OCC)S(=O)(=O)C1=CC(Cl)=CC(Cl)=C1 KJQBSILKDRJTBT-UHFFFAOYSA-N 0.000 description 1
• RYOPDNHWAAWRFD-UHFFFAOYSA-N n-[2-(1,3-benzothiazol-2-yl)naphthalen-1-yl]-3,5-dichlorobenzenesulfonamide Chemical compound ClC1=CC(Cl)=CC(S(=O)(=O)NC=2C3=CC=CC=C3C=CC=2C=2SC3=CC=CC=C3N=2)=C1 RYOPDNHWAAWRFD-UHFFFAOYSA-N 0.000 description 1
• IFLWMIQSGLQRSB-UHFFFAOYSA-N n-[2-(1,3-benzoxazol-2-yl)naphthalen-1-yl]-3,5-dichloro-n-(3,5-dichlorophenyl)sulfonylbenzenesulfonamide Chemical compound ClC1=CC(Cl)=CC(S(=O)(=O)N(C=2C3=CC=CC=C3C=CC=2C=2OC3=CC=CC=C3N=2)S(=O)(=O)C=2C=C(Cl)C=C(Cl)C=2)=C1 IFLWMIQSGLQRSB-UHFFFAOYSA-N 0.000 description 1
• PKECOODAYNIBIQ-UHFFFAOYSA-N n-[2-(1,3-benzoxazol-2-yl)naphthalen-1-yl]-3,5-dichloro-n-(diethoxyphosphorylmethyl)benzenesulfonamide Chemical compound N=1C2=CC=CC=C2OC=1C=1C=CC2=CC=CC=C2C=1N(CP(=O)(OCC)OCC)S(=O)(=O)C1=CC(Cl)=CC(Cl)=C1 PKECOODAYNIBIQ-UHFFFAOYSA-N 0.000 description 1
• LPVOPKDRFDBONC-UHFFFAOYSA-N n-[2-(1,3-benzoxazol-2-yl)naphthalen-1-yl]-3,5-dichlorobenzenesulfonamide Chemical compound ClC1=CC(Cl)=CC(S(=O)(=O)NC=2C3=CC=CC=C3C=CC=2C=2OC3=CC=CC=C3N=2)=C1 LPVOPKDRFDBONC-UHFFFAOYSA-N 0.000 description 1
• QTGBRFGDARMQHT-UHFFFAOYSA-N n-[6-[(3,5-dichlorophenyl)sulfonyl-(diethoxyphosphorylmethyl)amino]naphthalen-2-yl]-2-phenylacetamide Chemical compound C=1C(Cl)=CC(Cl)=CC=1S(=O)(=O)N(CP(=O)(OCC)OCC)C(C=C1C=C2)=CC=C1C=C2NC(=O)CC1=CC=CC=C1 QTGBRFGDARMQHT-UHFFFAOYSA-N 0.000 description 1
• FZQBDNDIDYVMGR-UHFFFAOYSA-N n-benzyl-1-[(3,5-dichlorophenyl)sulfonyl-(diethoxyphosphorylmethyl)amino]naphthalene-2-carboxamide Chemical compound C=1C(Cl)=CC(Cl)=CC=1S(=O)(=O)N(CP(=O)(OCC)OCC)C(C1=CC=CC=C1C=C1)=C1C(=O)NCC1=CC=CC=C1 FZQBDNDIDYVMGR-UHFFFAOYSA-N 0.000 description 1
• DSWUVURBSXGICA-UHFFFAOYSA-N n-benzyl-1-[(3,5-dichlorophenyl)sulfonylamino]naphthalene-2-carboxamide Chemical compound ClC1=CC(Cl)=CC(S(=O)(=O)NC=2C3=CC=CC=C3C=CC=2C(=O)NCC=2C=CC=CC=2)=C1 DSWUVURBSXGICA-UHFFFAOYSA-N 0.000 description 1
• HRYMOXHDNHHFOK-UHFFFAOYSA-N n-benzyl-5-[(3,5-dichlorophenyl)sulfonylamino]-n-methylnaphthalene-1-carboxamide Chemical compound C=1C=CC2=C(NS(=O)(=O)C=3C=C(Cl)C=C(Cl)C=3)C=CC=C2C=1C(=O)N(C)CC1=CC=CC=C1 HRYMOXHDNHHFOK-UHFFFAOYSA-N 0.000 description 1
• WHQAIOAEYNHGIV-UHFFFAOYSA-N n-benzyl-5-[(3,5-dichlorophenyl)sulfonylamino]naphthalene-1-carboxamide Chemical compound ClC1=CC(Cl)=CC(S(=O)(=O)NC=2C3=CC=CC(=C3C=CC=2)C(=O)NCC=2C=CC=CC=2)=C1 WHQAIOAEYNHGIV-UHFFFAOYSA-N 0.000 description 1
• BFHUYSOSOIXBLN-UHFFFAOYSA-N n-benzyl-6-[(3,5-dichlorophenyl)sulfonyl-(diethoxyphosphorylmethyl)amino]naphthalene-1-carboxamide Chemical compound C=1C(Cl)=CC(Cl)=CC=1S(=O)(=O)N(CP(=O)(OCC)OCC)C(C=C1C=CC=2)=CC=C1C=2C(=O)NCC1=CC=CC=C1 BFHUYSOSOIXBLN-UHFFFAOYSA-N 0.000 description 1
• 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
• KPTRDYONBVUWPD-UHFFFAOYSA-N naphthalen-2-ylboronic acid Chemical compound C1=CC=CC2=CC(B(O)O)=CC=C21 KPTRDYONBVUWPD-UHFFFAOYSA-N 0.000 description 1
• OELFLUMRDSZNSF-BRWVUGGUSA-N nateglinide Chemical compound C1C[C@@H](C(C)C)CC[C@@H]1C(=O)N[C@@H](C(O)=O)CC1=CC=CC=C1 OELFLUMRDSZNSF-BRWVUGGUSA-N 0.000 description 1
• 229960000698 nateglinide Drugs 0.000 description 1
• 230000017074 necrotic cell death Effects 0.000 description 1
• 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
• 201000001119 neuropathy Diseases 0.000 description 1
• 230000007823 neuropathy Effects 0.000 description 1
• 235000001968 nicotinic acid Nutrition 0.000 description 1
• 229960003512 nicotinic acid Drugs 0.000 description 1
• 239000011664 nicotinic acid Substances 0.000 description 1
• 150000002828 nitro derivatives Chemical class 0.000 description 1
• 229910017464 nitrogen compound Inorganic materials 0.000 description 1
• 150000002830 nitrogen compounds Chemical class 0.000 description 1
• 125000002868 norbornyl group Chemical group C12(CCC(CC1)C2)* 0.000 description 1
• 125000005482 norpinyl group Chemical group 0.000 description 1
• 229940078552 o-xylene Drugs 0.000 description 1
• 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
• VTRAEEWXHOVJFV-UHFFFAOYSA-N olmesartan Chemical compound CCCC1=NC(C(C)(C)O)=C(C(O)=O)N1CC1=CC=C(C=2C(=CC=CC=2)C=2NN=NN=2)C=C1 VTRAEEWXHOVJFV-UHFFFAOYSA-N 0.000 description 1
• 229960005117 olmesartan Drugs 0.000 description 1
• 230000003287 optical effect Effects 0.000 description 1
• 235000005985 organic acids Nutrition 0.000 description 1
• 150000007530 organic bases Chemical class 0.000 description 1
• 125000000962 organic group Chemical group 0.000 description 1
• 239000003960 organic solvent Substances 0.000 description 1
• 150000002902 organometallic compounds Chemical class 0.000 description 1
• 125000004043 oxo group Chemical group O=* 0.000 description 1
• RQKYHDHLEMEVDR-UHFFFAOYSA-N oxo-bis(phenylmethoxy)phosphanium Chemical compound C=1C=CC=CC=1CO[P+](=O)OCC1=CC=CC=C1 RQKYHDHLEMEVDR-UHFFFAOYSA-N 0.000 description 1
• NXJCBFBQEVOTOW-UHFFFAOYSA-L palladium(2+);dihydroxide Chemical compound O[Pd]O NXJCBFBQEVOTOW-UHFFFAOYSA-L 0.000 description 1
• 229920002866 paraformaldehyde Polymers 0.000 description 1
• 238000005192 partition Methods 0.000 description 1
• 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
• 208000033808 peripheral neuropathy Diseases 0.000 description 1
• 108091008765 peroxisome proliferator-activated receptors β/δ Proteins 0.000 description 1
• 239000000546 pharmaceutical excipient Substances 0.000 description 1
• 125000001792 phenanthrenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3C=CC12)* 0.000 description 1
• ANRQGKOBLBYXFM-UHFFFAOYSA-M phenylmagnesium bromide Chemical compound Br[Mg]C1=CC=CC=C1 ANRQGKOBLBYXFM-UHFFFAOYSA-M 0.000 description 1
• UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 1
• 229930029653 phosphoenolpyruvate Natural products 0.000 description 1
• DTBNBXWJWCWCIK-UHFFFAOYSA-N phosphoenolpyruvic acid Chemical compound OC(=O)C(=C)OP(O)(O)=O DTBNBXWJWCWCIK-UHFFFAOYSA-N 0.000 description 1
• 125000005541 phosphonamide group Chemical group 0.000 description 1
• 238000000053 physical method Methods 0.000 description 1
• 230000004962 physiological condition Effects 0.000 description 1
• 229960005095 pioglitazone Drugs 0.000 description 1
• 239000000106 platelet aggregation inhibitor Substances 0.000 description 1
• 229940093430 polyethylene glycol 1500 Drugs 0.000 description 1
• 229940093429 polyethylene glycol 6000 Drugs 0.000 description 1
• 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
• 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
• 229910052700 potassium Inorganic materials 0.000 description 1
• 239000011591 potassium Substances 0.000 description 1
• 108090000765 processed proteins & peptides Proteins 0.000 description 1
• 239000000047 product Substances 0.000 description 1
• BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
• 239000003881 protein kinase C inhibitor Substances 0.000 description 1
• CPNGPNLZQNNVQM-UHFFFAOYSA-N pteridine Chemical compound N1=CN=CC2=NC=CN=C21 CPNGPNLZQNNVQM-UHFFFAOYSA-N 0.000 description 1
• 238000000746 purification Methods 0.000 description 1
• 125000004076 pyridyl group Chemical group 0.000 description 1
• 230000006340 racemization Effects 0.000 description 1
• 238000000163 radioactive labelling Methods 0.000 description 1
• 239000000018 receptor agonist Substances 0.000 description 1
• 229940044601 receptor agonist Drugs 0.000 description 1
• 239000002464 receptor antagonist Substances 0.000 description 1
• 229940044551 receptor antagonist Drugs 0.000 description 1
• 102000005962 receptors Human genes 0.000 description 1
• 108020003175 receptors Proteins 0.000 description 1
• 238000001953 recrystallisation Methods 0.000 description 1
• 230000009467 reduction Effects 0.000 description 1
• 238000010992 reflux Methods 0.000 description 1
• 229960002354 repaglinide Drugs 0.000 description 1
• 238000011160 research Methods 0.000 description 1
• 229960004586 rosiglitazone Drugs 0.000 description 1
• CQRYARSYNCAZFO-UHFFFAOYSA-N salicyl alcohol Chemical group OCC1=CC=CC=C1O CQRYARSYNCAZFO-UHFFFAOYSA-N 0.000 description 1
• 239000012047 saturated solution Substances 0.000 description 1
• 238000000926 separation method Methods 0.000 description 1
• UNAANXDKBXWMLN-UHFFFAOYSA-N sibutramine Chemical compound C=1C=C(Cl)C=CC=1C1(C(N(C)C)CC(C)C)CCC1 UNAANXDKBXWMLN-UHFFFAOYSA-N 0.000 description 1
• 229960004425 sibutramine Drugs 0.000 description 1
• 239000000377 silicon dioxide Substances 0.000 description 1
• 229960002855 simvastatin Drugs 0.000 description 1
• RYMZZMVNJRMUDD-HGQWONQESA-N simvastatin Chemical compound C([C@H]1[C@@H](C)C=CC2=C[C@H](C)C[C@@H]([C@H]12)OC(=O)C(C)(C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 RYMZZMVNJRMUDD-HGQWONQESA-N 0.000 description 1
• MFFMDFFZMYYVKS-SECBINFHSA-N sitagliptin Chemical compound C([C@H](CC(=O)N1CC=2N(C(=NN=2)C(F)(F)F)CC1)N)C1=CC(F)=C(F)C=C1F MFFMDFFZMYYVKS-SECBINFHSA-N 0.000 description 1
• 239000011734 sodium Substances 0.000 description 1
• 229910052708 sodium Inorganic materials 0.000 description 1
• URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
• 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
• JVBXVOWTABLYPX-UHFFFAOYSA-L sodium dithionite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])=O JVBXVOWTABLYPX-UHFFFAOYSA-L 0.000 description 1
• 235000010288 sodium nitrite Nutrition 0.000 description 1
• 239000007787 solid Substances 0.000 description 1
• 238000001179 sorption measurement Methods 0.000 description 1
• 125000003003 spiro group Chemical group 0.000 description 1
• HXJUTPCZVOIRIF-UHFFFAOYSA-N sulfolane Chemical compound O=S1(=O)CCCC1 HXJUTPCZVOIRIF-UHFFFAOYSA-N 0.000 description 1
• 229940124530 sulfonamide Drugs 0.000 description 1
• 150000003456 sulfonamides Chemical class 0.000 description 1
• 150000003464 sulfur compounds Chemical class 0.000 description 1
• 229960000651 tasosartan Drugs 0.000 description 1
• ADXGNEYLLLSOAR-UHFFFAOYSA-N tasosartan Chemical compound C12=NC(C)=NC(C)=C2CCC(=O)N1CC(C=C1)=CC=C1C1=CC=CC=C1C=1N=NNN=1 ADXGNEYLLLSOAR-UHFFFAOYSA-N 0.000 description 1
• 229960005187 telmisartan Drugs 0.000 description 1
• RISRBOGLXAIVQY-UHFFFAOYSA-N tert-butyl n-(6-pyrimidin-2-ylnaphthalen-2-yl)carbamate Chemical compound C1=CC2=CC(NC(=O)OC(C)(C)C)=CC=C2C=C1C1=NC=CC=N1 RISRBOGLXAIVQY-UHFFFAOYSA-N 0.000 description 1
• 125000001302 tertiary amino group Chemical group 0.000 description 1
• 229950011008 tetrachloroethylene Drugs 0.000 description 1
• VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 1
• 125000006337 tetrafluoro ethyl group Chemical group 0.000 description 1
• 125000001412 tetrahydropyranyl group Chemical group 0.000 description 1
• OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
• 229940124597 therapeutic agent Drugs 0.000 description 1
• 230000001225 therapeutic effect Effects 0.000 description 1
• 150000001467 thiazolidinediones Chemical class 0.000 description 1
• 125000001544 thienyl group Chemical group 0.000 description 1
• YONPGGFAJWQGJC-UHFFFAOYSA-K titanium(iii) chloride Chemical compound Cl[Ti](Cl)Cl YONPGGFAJWQGJC-UHFFFAOYSA-K 0.000 description 1
• 229960005371 tolbutamide Drugs 0.000 description 1
• JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
• 229960004394 topiramate Drugs 0.000 description 1
• 229960002415 trichloroethylene Drugs 0.000 description 1
• 125000004044 trifluoroacetyl group Chemical group FC(C(=O)*)(F)F 0.000 description 1
• 125000004205 trifluoroethyl group Chemical group [H]C([H])(*)C(F)(F)F 0.000 description 1
• WRECIMRULFAWHA-UHFFFAOYSA-N trimethyl borate Chemical compound COB(OC)OC WRECIMRULFAWHA-UHFFFAOYSA-N 0.000 description 1
• CWMFRHBXRUITQE-UHFFFAOYSA-N trimethylsilylacetylene Chemical group C[Si](C)(C)C#C CWMFRHBXRUITQE-UHFFFAOYSA-N 0.000 description 1
• BZVJOYBTLHNRDW-UHFFFAOYSA-N triphenylmethanamine Chemical compound C=1C=CC=CC=1C(C=1C=CC=CC=1)(N)C1=CC=CC=C1 BZVJOYBTLHNRDW-UHFFFAOYSA-N 0.000 description 1
• NHDIQVFFNDKAQU-UHFFFAOYSA-N tripropan-2-yl borate Chemical compound CC(C)OB(OC(C)C)OC(C)C NHDIQVFFNDKAQU-UHFFFAOYSA-N 0.000 description 1
• LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
• 231100000397 ulcer Toxicity 0.000 description 1
• 229940116269 uric acid Drugs 0.000 description 1
• 230000003424 uricosuric effect Effects 0.000 description 1
• 229960004699 valsartan Drugs 0.000 description 1
• SJSNUMAYCRRIOM-QFIPXVFZSA-N valsartan Chemical compound C1=CC(CN(C(=O)CCCC)[C@@H](C(C)C)C(O)=O)=CC=C1C1=CC=CC=C1C1=NN=N[N]1 SJSNUMAYCRRIOM-QFIPXVFZSA-N 0.000 description 1
• PXXNTAGJWPJAGM-UHFFFAOYSA-N vertaline Natural products C1C2C=3C=C(OC)C(OC)=CC=3OC(C=C3)=CC=C3CCC(=O)OC1CC1N2CCCC1 PXXNTAGJWPJAGM-UHFFFAOYSA-N 0.000 description 1
• 229920002554 vinyl polymer Polymers 0.000 description 1
• 229960001729 voglibose Drugs 0.000 description 1
• UGZADUVQMDAIAO-UHFFFAOYSA-L zinc hydroxide Chemical compound [OH-].[OH-].[Zn+2] UGZADUVQMDAIAO-UHFFFAOYSA-L 0.000 description 1
• 229910021511 zinc hydroxide Inorganic materials 0.000 description 1
• 229940007718 zinc hydroxide Drugs 0.000 description 1
• DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 1